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AIM OF THE STUDY 
 
The aim of our study was to determine the outcome of head up tilt test in elderly 
patients with typical versus atypical features of syncope. 
 
OBJECTIVES OF THE STUDY 
 
1) To determine the outcome of head up tilt test in elderly patients aged sixty years 
and more who present with typical versus atypical history of syncope. 
2) To study the occurrence of various prodromal symptoms in syncope and their 
association with HUTT positivity. 
3) To study the association of HUTT response and comorbidities and comorbid 
burden. 
4) To study the association of syncope, type and HUTT response with medications 
taken by the subject. 
5) To study the association of syncope and  HUTT response with hand grip strength 
and mini cog test. 
6) To study the association of syncope and HUTT response with result of Holter test. 
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INTRODUCTION: 
 
     Syncope or fainting, falls, and dizziness are a major cause of morbidity and 
mortality in elderly patients. Syncope is defined as a sudden loss of consciousness 
associated with the inability to maintain postural tone, followed by spontaneous 
recovery. Retrospective studies have shown that up to 40% of the general 
population experience at least one episode of syncope in their life time. The 
incidence of syncope increases dramatically with advancing age. It has been 
reported that only half of patients over 85 years of age who are hospitalized with 
syncope survive more than three years. Syncope alone accounts for 3% of all 
emergency department visits and 6% of all hospital visits in all age groups. 
  Neurocardiogenic syncope (NCS), previously known as vasovagal syncope is the 
most common type of syncope among neurally mediated syncope.  The elderly 
population is more prone to NCS due to age related changes and multiple 
comorbidities like hypertension, atherosclerotic cerebrovascular disease and 
polypharmacy. The typical history of NCS includes three distinct phases: a 
prodrome or aura, loss of consciousness, and post-syncopal phase. A precipitating 
factor or situation is identiﬁable in most patients. Common precipitating factors 
include extreme emotional stress, anxiety, mental anguish, trauma, physical pain or 
anticipation of physical pain, warm environment, air travel, and prolonged 
standing.  
A typical NCS is characterized by precipitating triggers like emotional distress or 
orthostatic stress and prodromal symptoms due to activation of the autonomic 
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nervous system like nausea, vomiting, abdominal discomfort, pallor, sweating, 
feeling cold or warm, palpitations, yawning, sighing or urinary incontinence. The 
subject may have dizziness, lightheadedness or blurred vision due to reduced blood 
supply to the brain or retina of the eye. The commonest triggers in older 
individuals are prolonged standing and medications which cause vasodilatation. 
The diagnosis of NCS may be suggested or made by a specific history with well-
known triggers.  
In patients with atypical symptoms, the diagnosis is made by exclusion of other 
causes of syncope and by a characteristic response to upright tilt table testing, 
during which the patient may lose consciousness from low heart rate and/or low 
blood pressure. In the absence of a „gold standard „ diagnostic test for NCS , an 
appropriate clinical history in association with a positive head up tilt test currently 
provides the corner stone for the diagnosis of NCS. 
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LITERATURE REVIEW 
 
Syncope and falls are a major cause of morbidity and mortality in elderly patients.  
DEFINITIONS OF SYNCOPE: 
 
Syncope is defined as a transient loss of consciousness because of transient global 
hypoperfusion characterized by rapid onset, short duration and spontaneous and 
complete recovery.(1) 
Another definition of syncope is a transient loss of consciousness, associated with 
inability to maintain postural tone, rapid and spontaneous recovery and the absence of 
clinical features specific to other forms of transient loss of consciousness such as 
epileptic seizure.(2) 
TYPICAL SYNCOPE: 
 
In typical syncope, there is a period of prodromal symptoms in which, the patient may 
have symptoms such as light headedness, nausea, vomiting, sweating, visual 
disturbances and weakness, which warn the patient about the imminent syncope.(1) 
 In Typical syncope, the loss of consciousness is of short duration, usually for up to 20 
seconds, but rarely may last for several minutes. The recovery from syncope is usually 
with almost immediate restoration of orientation and appropriate behaviour, but the 
patient may have fatigue on the post recovery period.(1) 
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ATYPICAL SYNCOPE: 
 
In atypical syncope, the loss of consciousness occurs without warning symptoms. (1) 
 
PRESYNCOPE 
 
The words „pre-syncope‟ or „near-syncope‟ are used to describe a state like the 
prodrome of syncope but which is not followed by a loss of consciousness but it is 
doubtful whether the mechanisms are the same as that of syncope. 
 
EPIDEMIOLOGY 
 
In a cross sectional survey of one thousand nine hundred and twenty five residents 
who were randomly selected from the Olmstead county Minnesota from January 1998 
to August 2000, who were forty five years of age or older, the prevalence of syncope 
was around  nineteen per cent with a higher prevalence in females. Overall, three 
hundred and sixty four of the subjects reported having had one episode of syncope. 
Ten per cent of the subjects reported injury due to syncope. About half of the subjects 
who had syncope reported at least one recurrent episode of syncope.(3) 
Prior to 2002, the epidemiology of syncope was not well described and data was 
limited on the lifetime incidence of syncope. 
In the Framingham heart study, of the 7814 study participants who were followed for 
an average of 17 years, 822 reported having syncope. Similar incidence was found in 
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men and women.  The incidence of a first report of syncope was 6.2 per 1000 person-
years. The causes identified were vasovagal (21.2%), cardiac (9.5%), and orthostatic 
(9.4%) and for 36.6% the cause was unknown. Also, in the study, the incidence was 
found to rise sharply after 70 years. 
Also, it was concluded that persons with cardiac syncope were at an increased risk for 
death from any cause and cardiovascular events, and persons with syncope without a 
known cause were at an increased risk for death from any cause. (4) 
A Danish nationwide observational study done which included one hundred and 
twenty thousand five hundred and eight patients presenting with syncope from 1997 to 
2009 looked at the incidence of syncope and its association with pharmacotherapy and 
comorbidities. Syncope was found to be more common in females (52.6 per cent of all 
the cases) and they were also relatively older than men at diagnosis time with an 
average age of sixty six years as compared to sixty three years in males and the 
median age was sixty five years. Forty three per cent of these patients required 
admission. 
The incidence among different age groups in the study was found to be trimodal with 
three peaks. The first episode was common at the ages of twenty, sixty and eighty 
years. The third peak occurred five to seven years earlier in males. 
Cardiovascular disease was found to be common in the syncope population. Eleven 
per cent of the patients were known to have ischemic heart disease and 9.4 per cent 
had arrhythmias. Twenty nine percent of the patients were on diuretics, twenty per 
cent on ACE inhibitors, sixteen per cent on beta blockers and eleven percent were on 
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statins. Anxiolytics and antidepressants were also commonly used, especially in 
females and elderly.(5) 
Another study published in 1992 found that syncope accounts for one to 6 per cent of 
all hospital admissions.(6) 
A study of five hundred and forty nine individuals from general population aged thirty 
five to sixty years revealed the lifetime cumulative incidence of syncope to be thirty 
five per cent, more commonly in women (forty one per cent) as compared to men 
(twenty eight per cent), peak incidence around the age of fifteen years in both men and 
women.(7) 
A study was done in two hundred and eight patients with positive result on head up tilt 
test and more than or equal to three episodes of syncope in their lifetimes. They were 
followed up for a year for recurrence. It was found that a history of no syncope in the 
preceding year was associated with a seven per cent probability of recurrence of 
syncope while any history of syncope in the preceding year was associated with a 
forty six per cent probability for recurrence of syncope.(8) 
PREVALENCE OF SYNCOPE IN THE ELDERLY 
 
Another retrospective cohort study was done in more than one thousand and five 
hundred patients belonging to predominantly geriatric population to describe the 
etiologies of syncope in patients who were hospitalized and to determine factors 
influencing survival after discharge. It was found that nineteen per cent of these 
patients had cardiovascular causes of syncope, most common of which were 
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arrhythmias. But ventricular tachycardia and complete heart block accounted for only 
two per cent of the cases each. 
In this hospitalized cohort of elderly, non cardiovascular syncope was twice as likely 
as cardiogenic syncope. Age and comorbidity had impacted the survival but cause of 
syncope as determined by treating doctor did not affect the prognosis. They also found 
that hospitalized elderly had had twice as likely a chance to have a non cardiovascular 
syncope. 
Forty two per cent of the patients did not have an established diagnosis of syncope at 
the time of discharge. 
Also, the cohort of patients with syncope had a seventy nine per cent higher risk of 
dying over a four year period than their matched cohorts and it was strongly related to 
comorbid burden and age.(9) 
Although common in the elderly, little is known about the prognosis and 
epidemiology of syncope in this population. A retrospective analysis of syncope was 
done in seven hundred and eleven very old institutionalized patients with a mean age 
of eighty seven years. The ten year prevalence was twenty three per cent. This 
population was prospectively followed up for two years and a yearly incidence was 
found to be six per cent and recurrence rate was thirty per cent. Sixty seven patients 
developed syncope during follow up. In forty six of these, a cause could be established 
and in twenty one patients, the cause of syncope was unexplained. Fourteen of these 
patients had a cardiac cause and thirty two had non cardiac cause of syncope. Syncope 
was more common in patients with more comorbid conditions and it was opined to be 
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a likely manifestation of the comorbidities rather than contributing independently to 
mortality.(10) 
 
PATHOPHYSIOLOGICAL BASIS FOR SYNCOPE 
 
EVOLUTIONARY ASPECT: 
 
One of the defining feature of human evolution was acquiring an upright posture to 
become bipedal. With this, a new challenge was posed to the control of blood 
pressure. Normally 25 per cent of the blood volume is in the thorax. After assuming 
an upright posture, gravity displaces around half a litre of blood to the lower limbs and 
the abdomen. About half of this is redistributed after standing within seconds. This 
results in a reduction in the venous return to the heart and the stroke volume may 
reduce by forty per cent. Normally, orthostatic stabilization is achieved within one 
minute of standing. Due to a slow decrease in the venous return, there is activation of 
the baroreceptors in the aortic arch and the carotid sinus and in the heart and lungs 
which are linked by unmyelinated vagal afferents in atria and ventricles. This has an 
inhibitory effect on the medullary cardiovascular centres.this reduces the discharge 
rate to the brainstem input leading to increased sympathetic outflow and causes 
systemic vasoconstriction. Simultaneously, a decrease in blood pressure is also sensed 
by baroreceptors in the carotid sinus and causes increase in the heart rate. This early 
adaption leads to a 10-15 beats per minute increase in the heart rate and about 10 mm 
Hg rise in the diastolic blood pressure and little or no change in the systolic blood 
pressure.(11)   
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HUMAN BRAIN AND ITS PERFUSION: 
 
The human brain weighs 1.4 kg, about two per cent of the average body weight but 
required fifteen to twenty per cent of the cardiac output at rest and has little metabolic 
reserve. So, an adequate cerebral perfusion is essential.(12) 
A sudden cessation of blood flow to the brain for short duration of 6–8 seconds is 
sufficient to cause a complete loss of consciousness. Experience from tilt table testing 
has shown that a reduction in systolic BP to 60 mmHg or lower is associated with 
syncope. 
NEUROHUMORAL MECHANISM: 
 
A critical component required for maintenance of mean arterial blood pressure and 
thus the cerebral blood flow is the baroreflex system. The most well known sensors of 
the baroreflex system are situated in the aortic arch and the carotid sinuses. The 
vascular triggered baroreflex arc consists of: 
1. Afferents from carotid sinus baroreceptors relaying in glossopharyngeal nerve 
2. Afferents from aortic baroreeceptors relaying in vagus nerve 
These afferents converge in medulla oblongata in the nucleus tractus solitariius, where 
they are integrated with other sensory inputs. The efferents for the reflex syncope are 
carried in the sympathetic nerves to the heart and the peripheral blood vessels and in 
the parasympathetic nerves to the heart and the gastrointestinal tract (small intestine 
and up to splenic flexure of the large intestine).  
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BAROREFLEX MECHANISM 
 
In healthy individuals, if there is an increase in the mean arterial blood pressure, it is 
sensed by the carotid sinus and aortic arch baroreceptors and leading to an increase in 
the parasympathetic flow to the heart leading to a reduction in the heart rate and 
contractility. Simultaneously, the sympathetic outflow is also reduced to the 
vasculature. This causes a drop in the peripheral resistance. The vagal effects on the 
contractility and heart rate is instantaneous but the sympathetic effects take two to 
three seconds to take effect. Likewise, the withdrawal of sympathetic effect takes 
longer time to manifest compared to the parasympathetic tone withdrawal. 
Conversely, a drop in the mean arterial blood pressure or the venous return to heart 
causes a reduction in the afferent signals from the baroreceptors and an alteration in 
the efferent flow then raises the mean arterial blood pressure.(12) 
It is hypothesized that vigorous myocardial contraction induces discharge of vagal 
efferents via ventricular mechanoreceptors which produces sympathoinhibition and 
parasympathetic discharge. A sudden inappropriate bradycardia has been reported 
after an initial tachycardia during significant haemorrhage and a similar response is 
seen during head up tilt test.(13) 
Vasovagal syncope is a disorder of cardiovascular autonomic regulation.(14) An 
essential feature in all forms of syncope is a drop in the mean arterial blood pressure. 
If the cause for this decrease in the mean arterial blood pressure is venous or arterial 
dilation, causing blood trapping in the lower limbs or splanchnic beds without 
bradycardia, the syncope is called as vasodepressor syncope. This results from a 
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decrease in the arteriolar or venous vasoconstriction which is sympathetically 
mediated. 
But in most of the cases, the reflex syncope is associated with a marked or relative 
decrease in the heart rate, when it is known as cardioinhibitory syncope. This is due to 
an increase in the vagal stimulation to the sinus node or the AV node or both. 
The Systemic blood pressure is determined by cardiac output and peripheral vascular 
resistance, and a drop in either of these can cause syncope, but a combination of may 
be present. Based on the underlying pathophysiology, syncope can be of the following 
types: 
REFLEX SYNCOPE OR NEUROCARDIOGENIC SYNCOPE:     
   
Reflex syncope is a heterogeneous group of conditions in which cardiovascular 
reflexes that normally control the circulation become intermittently inappropriate, in 
response to a trigger, causing vasodilatation and/or bradycardia resulting in a fall in 
the arterial blood pressure and reduced global cerebral perfusion. The reflex syncope 
is of the following types:     
 
a. VASOVAGAL SYNCOPE (VVS): 
 it is the most common form of reflex syncope and is mediated by emotion 
or orthostatic stress and is usually preceded by prodromal symptoms of 
autonomic activation. It usually occurs in the upright position, usually 
standing, but also in sitting position or due to exposure to pain, stress or 
medical settings. 
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It is associated with pallor, nausea, pallor or warmth and the patient has 
inappropriate bradycardia or hypotension or both and is usually followed 
by fatigue. The above are the typical features which may be absent in the 
elderly. The vasovagal syncope usually has these prodromal features and 
identifiable risk factors. The diagnosis of vasovagal syncope is primarily 
based on a thorough history, examination and eyewitness account if 
available.(15) 
 
b. SITUATIONAL SYNCOPE 
 reflex syncope associated with specific circumstances such as cough, 
sneezing, gastrointestinal stimulation like swallowing, defecation, visceral 
pain, micturition, exercise, meals and others like laughter, playing brass 
instruments and weight lifting. 
 
c. CAROTID SINUS SYNCOPE 
 a rare spontaneous form which is triggered by mechanical manipulation of 
the carotid sinuses. Carotid sinus hypersensitivity is defined as a pause of 
more than or equal to three seconds or a reduction in the systolic blood 
pressure by more than or equal to fifty mm Hg on stimulating the carotid 
sinus. It is more commonly seen in the elderly and can have varying 
degrees of symptoms.(15) 
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Neurocardiogenic syncope accounts for more than eighty per cent of 
syncopal events. On exposure to stimuli like prolonged standing, the 
brainstem vasomotor centre initiates a reflex. The vasomotor centre 
maintains the normal contraction level of blood vessels.  But in case of 
syncope the vasomotor centre signals the blood vessels in the lower limbs 
to dilate and also causes a drop in the heart rate. This causes pooling of 
blood in the lower limb veins, reducing the cerebral perfusion and causing 
syncope. As the patient has a fall, gravity no longer acts to pull the blood 
away from brain and the patient regains consciousness.(16) 
To determine the spectrum of neutrally mediated cause of syncope, a study 
was done in four hundred and sixty one patients who had syncope, of 
which, two hundred and eighty were found to have neurally mediated 
syncope. Using a questionnaire and a set of standardized diagnostic criteria, 
the cause of syncope was assigned. It was found that thirty nine of these 
had typical vasovagal syncope, while carotid sinus syncope and situational 
syncope were found in thirty four patients each. One hundred and forty two 
of these patients were found to have head up tilt table test positive result 
and a complex neurally mediated cause which was positive for both carotid 
sinus massage and head up tilt test was found in thirty one of the 
patients.(17) 
In a cohort comprising of five hundred and three patients who presented 
with a transient loss of consciousness , the occurrence of triggers and 
prodromal symptoms was analysed by gender and age. It was found that 
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reflex syncope was the most common diagnosis among these patients 
occurring in more than sixty per cent of patients belonging to all age 
groups. It was more frequent (73.4 per cent) in younger patients (less than 
forty years) compared to patients over sixty years of age (45.3 per cent). 
The most commonly reported prodromal signs and symptoms were pallor, 
dizziness and diaphoresis. Syncope was found to be more common in 
females. Also, typical features of syncope were less common in males and 
the elderly.(18) 
 
 
ORTHOSTATIC HYPOTENSION AND ORTHOSTATIC INTOLERANCE 
SYNDROME: 
 
Classical orthostatic hypotension is defined as a decrease in systolic blood pressure of 
more than 20 mmHg and in diastolic BP of more than 10 mmHg within 3 minutes of 
standing. In autonomic nervous system failure, the sympathetic efferent activity is 
chronically impaired which leads to reduced vasoconstriction due to which, upon 
standing, the blood pressure falls and syncope or pre-syncope occurs. 
 
Initial or immediate orthostatic hypotension is defined as a transient decline in blood 
pressure within 15 seconds of standing which can be with syncope or presyncope. 
Delayed orthostatic hypotension is defined as a sustained decrease in the systolic 
blood pressure by more than or equal to 20 mm Hg (or by 30 mmHg on patients with 
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supine hypertension) or in the diastolic blood pressure by more than or equal to 10 
mm Hg which takes more than three minutes of patient being in the upright 
posture.(15) 
Neurogenic orthostatic hypotension is a subtype of orthostatic hypotension which is 
because of autonomic nervous system dysfunction and not only because of external 
triggers like dehydration or drugs. Usually it is because of lesions of the peripheral or 
central autonomic nerves.(15) 
 
 
NEUROCHEMICAL PATHOPHYSIOLOGY OF SYNCOPE: 
 
An increased sympathetic activity is usually observed before a vasovagal syncope. 
Adenosine, in addition to having a direct vasodilatory and bradycardiac effect can also 
increase the sympathetic activity by stimulating the cardiovascular afferents. A study 
done in eighty five patients to look at the effects of adenosine and head  up tilt test  
with or without isoproterenol and adenosine was given to the patients in the upright 
position. A transient tachycardia or hypertension in the immediate phase (first 15 
seconds) was observed in 67 per cent of patients after administration of 6 mg of 
adenosine and in 24 per cent patients after administration of 12 mg of adenosine. This 
suggested a direct sympathetic activation. But in the delayed phase, that is 15 to 60 
seconds after the adenosine injection, reflex tachycardia and hypotension were 
observed in all the patients. A vasovagal reaction was induced in 26 per cent of 
patients who were given adenosine and in 34 per cent of patients who underwent a tilt 
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table test and the vasovagal response to induction by these two methods was found to 
be comparable. This observation supported the idea that adenosine can have a role in 
the triggering of a vasovagal response by causing a direct sympathetic activation 
(cardiac afferent excitatory nerves ) and indirect sympathetic effect (reflex 
sympathetic activation and vasodilation).(19) 
 
 
PATHOPHYSIOLOGY IN ATYPICAL SYNCOPE: 
 
Atypical syncope occurs without a prodrome. If it occurs in patients with an 
underlying structural cardiac disease, it is thought to be ominous, suggestive of a 
cardiac arrhythmia as a cause of syncope, also known as Stokes-Adams attack. But if 
the ECG does not show abnormalities of conduction and there is no structural cardiac 
disease, a cardiac cause of syncope is unlikely and electrophysiological studies are 
commonly negative. So, in patients who have syncope without prodrome with normal 
ECG and no structural abnormality, the syncope is unexplained. To find the cause, a 
study was done in which, fifteen patients presented with syncope without a prodrome 
with thirty one patients with typical vasovagal syncope as controls with well identified 
triggers which included emotional distress and prolonged standing and preceding 
autonomic symptoms of warmth, lightheadedness, dizziness, nausea and sweating. 
Atypical forms of syncope such as those without identifiable triggers or short 
prodromes were excluded. A baseline adenosine plasma level was checked and the 
subjects underwent head up tilt test and an adenosine triphosphate test. It was found 
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that the study subjects were older, had fewer episodes of syncope, had lower 
frequency of positivity in the head up tilt test, had lower median baseline adenosine 
plasma level and had similar level of positivity for adenosine triphosphate testing as 
controls. So, it was hypothesized that these patients had a “Low Adenosine syncope” 
which was characterized by onset in the middle or old age, normal cardiac structure 
and ECG and sudden onset  without prodrome .(20) 
 
CARDIAC SYNCOPE OR CARDIOVASCULAR SYNCOPE: 
 
  It is caused by tachycardia, bradycardia or hypotension due to a low cardiac 
index, obstruction to the blood flow, acute vascular dissection or vasodilatation. 
a. ARRHYTHMIA 
Arrhythmias are a common cause of cardiac syncope and induce 
haemodynamic impairment, which can lead to a critical decrease in the cardiac 
output and thereby the  cerebral blood flow. 
The findings in the ECG which suggest an arrhythmic cause of syncope are: 
Presence of a bifascicular block defined as either RBBB along with left anterior 
or posterior fascicular block or with LBBB  
Intraventricular conduction abnormalities (like prolonged QRS interval of more 
than or equal to 0.12 seconds) 
Ventricular tachycardia (non sustained) 
Mobitz type I heart block 
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Inappropriate sinus bradycardia (heart rate of less than fifty beats per minute), 
sinus pause of more than or equal to three seconds or sinoatrial block when the 
patient is not on any negatively chronotropic medication 
Early repolarization 
Pre excited QRS 
Short or long QT intervals 
Q waves suggestive of myocardial infarction 
ST elevation in the leads V1 to V3 with RBBB pattern (Brugada syndrome) 
T wave inversion in the right precordial leads 
(21)  
 
b. INTRINSIC SICK SINUS SYNDROME: 
In this, the sinoatrial node is damaged, which leads to syncope  due to long 
pauses caused by sinus arrest or sinoatrial block and pauses are most frequently 
encountered when an atrial tachyarrhythmia suddenly stops (brady-tachy 
syndrome) leading to cerebral hypoperfusion. 
c. Atrioventricular blocks 
d. Paroxysmal tachycardia 
e. Structural cardiac diseases 
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POSTURAL ORTHOSTATIC TACHYCARDIA SYNCROME (POTS) 
It is characterized by frequent symptoms of palpitations, tremulousness, light 
headedness, blurred vision, generalized weakness, fatigue and exercise 
intolerance which occur after standing. There is an increase in the heart rate by 
more than or equal to 30 beats per minute during a change of positíon from 
supine to standing and the systolic blood pressure does not decline by more 
than 20 mm Hg. Other symptoms include fatigue, sleep disturbance and 
migraine headaches and often, the standing heart rate is more than 120 beats 
per minute.(15) 
An analysis of data from the patients enrolled in SCD-HeFT trial (Sudden 
cardiac death heart failure trial) to determine whether syncope predicted 
outcome in patients with heart failure revealed that nineteen per cent of the 
subjects had syncope over a follow up period of 45.5 months and three per cent 
of all enrolled patients had more than one episode of syncope.  After 
randomization, it was found that the patients with syncope had an increased 
risk of all cause mortality than those without syncope and an increased 
cardiovascular death risk, but the risk of sudden cardiac death was not 
increased significantly.(22) 
 
HISTORY AND CLINICAL PRESENTATION: 
The first step in finding whether the episodes of transient loss of consciousness 
are due to true syncope or some other cause is obtaining a thorough medical 
history. The frequency, number and duration of syncopal episodes and the 
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period over which the patient had these episodes are important. The longer the 
time duration over which the patient has had syncopal episodes, the lesser 
likely is the cause of syncope to be life threatening. Also, a history of multiple 
episodes occurring over a short duration is more likely to have a serious 
underlying disorder. 
Most patients with syncope present with a prodrome for a few seconds before 
losing consciousness. But a sudden loss  of consciousness without any warning 
symptoms is more common in patients with cardiac cause of syncope. 
The loss of consciousness in syncope may occur with or without warning signs 
like dizziness, lightheadedness, sweating, nausea, visual disturbances or 
weakness, but may also occur without warning. Typical syncope is short lasting 
and may be up to 20 seconds in duration. Sometimes, accurate duration may be 
difficult to find out. But rarely, a syncopal episode may last longer up to 
several minutes and in these cases, it is difficult to differentiate it from other 
causes of loss of consciousness, especially seizures. According to a study done 
in 94 patients, it was found that the best finding to discriminate seizures from 
syncope was the patient‟s orientation immediately after the episode. It was 
found that if the patient was disoriented after the event, a seizure was almost 
five times more likely than syncope. Also, incontinence and trauma were not 
discriminatory among seizure and syncope and if the patient had sweating or 
nausea before the seizure, it was helpful to exclude seizure.(23) 
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A study was done to find out what findings in the history were predictive of 
cause of syncope in three hundred and forty one patients based on a 
questionnaire. In this study, it was found that most of the patients (one hundred 
ninety nine or fifty eight per cent of the patients) had a neurocardiogenic 
syncope). This was followed by a cardiac cause which was found in seventy 
eight (twenty three per cent) of the patients. In sixty patients (eighteen per cent) 
the cause of syncope was unexplained.(24) 
 
Following are the historical factors which are associated with a higher 
probability of cardiac cause of syncope: 
- Males 
- old age(more than sixty years) 
- short prodrome of palpitations or sudden loss of consciousness without 
prodrome 
- presence of known structural or ischemic heart disease, reduced ventricular 
function or previous arrhythmias 
- Syncope during exertion 
- one or two episodes of syncope (low number) 
- syncope in the supine position 
- known heart disease which is congenital 
- family history of sudden cardiac death in less than 50 years of age or 
inheritable conditions 
- abnormal cardiac examination 
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Following are the factors which are more often associated with a non cardiac 
cause of syncope: 
- younger age 
- syncope in the standing position only 
- no known cardiac disease 
- presence of prodrome like warmth, nausea, vomiting 
- situational triggers like swallowing, urination, defecation, coughing, laughing 
etc. 
- triggering factors like pain, medical environment, stressful stimulus, 
dehydration 
- prolonged history of syncope with same characteristics and recurrences(15) 
 
OTHER CAUSES OF TRANSIENT LOSS OF CONSCIOUSNESS: 
 
Metabolic causes: 
  -hypoxia 
  -hypoglycemia 
  -hyperventilation 
Psychiatric causes: 
  -Somatisation disorders 
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  -hysteria 
  -Panic 
  -fright  
Neurological causes: 
  -seizure disorders 
  -transient ischemic attacks 
  -Subclavian steal syndrome 
  -normal pressure hydrocephalus 
(25) 
Based on the history, there are several clues which point to the type of syncope 
as follows: 
 
History and clinical features that suggest neutrally mediated syncope are: 
Recurrent syncope with a long history 
No underlying heart disease 
Prolonged standing or hot, crowded places 
After unexpected sudden unpleasant smell, sound, sight or pain 
During or after a meal 
Nausea or vomiting with syncope 
After exertion 
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Associated with rotation of the head or pressure on the carotid sinus such as 
shaving, tight collars or tumors 
 
History and clinical features that suggest syncope due to orthostatic 
hypotension are: 
When syncope occurs after standing up 
When it has a temporal association with initiation or dose change of a 
vasodepressive medication causing hypotension 
Disorders causing autonomic neuropathy like Parkinsonism 
Prolonged standing in hot crowded places 
Standing after exertion 
 
History and clinical features suggesting a cardiovascular cause of syncope are: 
Family history of sudden cardiac death 
Definite structural heart disease 
Syncope occurring during exertion or in a supine position 
Sudden palpitations which are followed immediately by syncope 
(21) 
Of the causes of syncope, vasovagal syncope is the most common and is 
difficult to diagnose as often the patients have cannot recollect the history of 
unconsciousness. 
Vasovagal syncope is defined as a syncope syndrome that usually 
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a. Occurs with upright posture held for more than thirty seconds or with 
exposure to emotional stress, pain or medical settings 
b. Features such as diaphoresis, warmth, pallor and nausea 
c. Has association with relative bradycardia and hypotension, when known 
d. Is followed by fatigue(2) 
 Many causes of syncope are treatable or have a poor eventual outcome. But 
vasovagal syncope is not associated with excess mortality. Due to this 
diagnostic uncertainty based on the history and concern regarding an 
underlying treatable and potentially dangerous cause leads to over investigating 
patients of syncope with expensive investigations. 
A study of billing records of one hundred and  sixty seven patients with the 
diagnosis of syncope revealed the diagnosis in 48.3 per cent patients. Postural 
blood pressure provided the maximum diagnostic yield followed by history 
taking which diagnosed 19.7 per cent of the cases.The diagnostic yield of the 
various tests were as follows: Electroencephalogram telemetry 4.6 per cent, 
ECG 4.24 per cent, Radionuclide stress test 3.44 per cent, echocardiography 
0.94 per cent and troponin 0.62 per cent. The chest x ray, ultrasound, carotid 
Doppler and MRI and Computed tomogram of the brain and twenty four hour 
Holter monitoring did not give the diagnosis in any patient. Less than two per 
cent of the money spent in syncope evaluation led to a definitive diagnosis. 
Postural blood pressure measurement had the maximum cost to benefit 
ratio.(26) 
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 So, simple diagnostic tools are needed for a diagnosis. A study looked at 
simple diagnostic criteria based on a careful history using a questionnaire to 
distinguish vasovagal from other causes of syncope in patients with no 
structural cardiac abnormality. In this study, patients with a positive tilt test 
were given a structured questionnaire and the response was compared with 
patients with syncope due to other causes which were known. Using this, a 
diagnostic score was developed to differentiate vasovagal from other causes of 
syncope. The head up tilt test positivity was considered the gold standard 
diagnostic criteria for diagnosis of vasovagal syncope. It was found that the 
patients with tilt test positive primary syncope were younger and more women 
belonged to this category than secondary syncope. The derived point score had 
a true overall accuracy of 89.7 per cent , an true specificity of 90.8 per cent and 
a true sensitivity of 89.3 per cent. The features of history that were contributory 
to tilt positive primary syncope diagnosis were exposure to pain or a medical 
procedure, warmth or diaphoresis and association with prolonged standing or 
sitting. Factors that strongly predicted syncope which was secondary to other 
causes were asystole, bifascicular block, diabetes or supraventricular 
tachycardia, cyanosis and older age at onset.(27) 
 
PROGNOSIS OF SYNCOPE: 
In a study aimed at finding the short and long term outcome of syncope, six 
hundred and seventy patients were included, all recruited from the emergency 
department, sixty seven per cent were discharged directly from the emergency 
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department and the remaining were admitted. Forty one subjects had severe 
outcomes including five deaths and thirty six early readmission or major 
therapeutic procedures. Forty of the forty one subjects with severe outcomes 
were more than seventy years of age and four of the five deaths occurred within 
forty eight hours of emergency department evaluation. The univariate analysis 
showed that significantly associated risk factors with severe short term 
outcomes were age more than sixty five years, male sex, and coexistence of 
heart failure, structural heart disease, trauma, chronic obstructive airway 
disease, abnormal ECG and the absence of premonitory symptoms. But a 
multivariate analysis showed significant association of severe outcomes with 
abnormal ECG at the time of presentation, absence of premonitory symptoms, 
concomitant trauma and male sex. A one year follow up could be done for six 
hundred and sixty seven patients. One year mortality was six per cent and 3.3 
per cent had other severe outcomes than death. A multivariate analysis revealed 
that the risk factors significantly associated with severe outcomes after one 
year were age more than sixty five years and the co existence of neoplasms, 
structural heart disease, cardiovascular diseases or ventricular arrhythmias. In 
case of vasovagal events, there was a virtual absence of mortality at 12 
months.(28) 
 
DIAGNOSIS OF SYNCOPE: 
In patients presenting with features suggestive of syncope, an initial evaluation 
entails a detailed history, physical examination and an ECG. If the initial 
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evaluation is clear, no additional evaluation is required.  If the initial evaluation 
suggests neurogenic orthostatic hypotension, an autonomic evaluation should 
be done. But if the initial evaluation is suggestive of a reflex syncope, a tilt 
table test should be performed. However, if the initial evaluation suggests 
cardiovascular abnormalities, a cardiac monitoring should be done based on the 
nature and frequency of the episodes. The diagnostic modalities for evaluation 
of cardiac cause of syncope are Stress testing, Transthoracic ECHO, 
Electrophysiological studies and CT or MRI 
 
APPROACH TO SYNCOPE: 
a. History, physical examination and ECG  
b. Carotid sinus massage may be useful in elderly but should be avoided if the 
patient has carotid bruits, a history of ventricular tachycardia or a recent 
history of myocardial infarction or stroke. 
c. Special issues for geriatric patients include multifactorial nature, use of 
carotid massage, polypharmacy and cardiac testing such as exercise stress 
testing and echocardiography to exclude cardiac pathology. 
d. Arrhythmias found on Holter recording which are non diagnostic should not 
be usually treated 
e. In patients with organic heart disease and syncope which is otherwise 
unexplained should undergo intracardiac electrophysiologic studies. 
f. Echocardiography should be done before exercise stress testing in patients 
having a history of syncope after exertion. 
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g. In patients with recurrent syncope having a structurally normal heart, the 
assessment should include psychiatric evaluation and a loop recorder. 
h. Tests like neurological evaluation including electroencephalography, 
transcranial and carotid Doppler and imaging procedures like Computed 
tomography should be reserved for individuals with neurological signs or 
carotid bruit.(29) 
The initial evaluation including history, physical examination and ECG. If it is 
diagnostic of vasovagal syncope, orthostasis or polypharmacy, no further evaluation is 
required and the patient should be treated appropriately.  
But if the initial evaluation is suggestive of an underlying cause like aortic stenosis, 
family history of syncope or sudden death or neurological symptoms, specific tests 
like echocardiogram, cardiac catheterization, lung scan, electroencephalogram and CT 
of the brain should be done and once the cause is found, it should be managed 
accordingly. 
However, if the syncope is still unexplained and the patient has features of an organic 
cardiac disease as suggested by exertional symptoms, sudden syncope without 
prodrome and an abnormal ECG, ECHO or treadmill test, Holter should be done. 
Based on the holter report, the patients can be subdivided in the following 
management schemes: 
a. If the symptoms occur with normal sinus rhythm, further work up for 
arrhythmia should be stopped. If the patient continues to have recurrent 
syncope, a tilt test and psychiatric evaluation should be done. 
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b. If the Holter is suggestive of arrhythmia and the patient has symptoms during 
arrhythmia, the arrhythmia should be treated. 
c. If the Holter test is non diagnostic, electrophysiology tests shoukd be done and 
if diagnostic, be treated. 
But if both Holter and electrophysiology tests are inconclusive, the further approach 
depends on the frequency of episodes. For an isolated first episode of syncope, work 
up should be stopped. If the episodes are infrequent, tilt table test and psychiatric 
evaluation should be done. But for frequent episodes, loop ECG monitor, tilt test and 
psychiatric evaluation should be done. 
In case of unexplained syncope in elderly, carotid sinus massage should be done. 
 
a. Organic heart disease: suggested by exertional symptoms and sudden syncope 
A prospective observational study was done with eighteen months of follow up 
in 650 patients presenting with syncope. There was either a clinical suspicion 
of a valvular cardiac disease or the syncope was not explained by history or 
clinical examination or ECG and the patients underwent a transthoracic 
echocardiography.  Over a period of 20 months, of the seven hundred and 
eighty eight patients presenting to the emergency department with a history of 
syncope, six hundred and fifty were enrolled in the study with a mean age of 
fifty five years. After initial evaluation and targeted diagnosis, a probable cause 
of syncope could be assigned in four hundred and ninety five of the six hundred 
and fifty cases. These included a vasovagal cause in forty seven per cent of the 
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patients, hypotension in thirty two per cent, psychiatric and neurological 
disorders in eight per cent,  cardiac diseases in six per cent (including 
pulmonary embolism, acute myocardial infarction or aortic stenosis) and 
arrhythmias in five per cent. 
All patients had echocardiography of which, more than half (54 per cent) were 
normal. Of the eighty eight patients with a history of cardiac disease or 
abnormal ECG, Echocardiography was normal in fifty (seventy three per cent) 
and non relevant in seventeen. Twenty four patients (27 per cent) had left 
ventricular ejection fraction less than 40 per cent. These results showed that an 
echocardiogram was important to evaluate patients with unexplained syncope 
with an abnormal ECG or a positive history of cardiac disease. If 
echocardiography was restricted to these high risk patients, it gave useful 
information to assess severity of the underlying cardiac disease and risk 
stratification.(30) 
 
HEAD UP TILT TABLE TESTING: 
Till date, this is the only tool which has undergone clinical scrutiny to identify the 
susceptibility to vasovagal response in patients with syncope. It simulates conditions 
precipitating the syncopal episode in a clinically controlled setting. This is based on 
the following observations: 
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a. Both spontaneous and induced syncopal episodes are associated with 
similar symptoms such as nausea and diaphoresis and signs like pallor and 
loss of postural tone. 
b. The temporal sequence of changes in heart rate and blood pressure which 
occur during the head up tilt test induced syncope parallel the changes that 
are reported for spontaneous episodes. 
c. The catecholamine level measured during tilt table test induced and 
spontaneous episodes of syncope  are similar.(31) 
 
DIAGNOSTIC ACCURACY: 
SPECIFICITY OF HEAD UP TILT TEST 
The lack of a gold standard test for diagnosis of vasovagal syncope makes the 
specificity and sensitivity difficult to assess. A study designed to evaluate specifity of 
head up tilt test in one hundred and fifty normal subjects with no history of 
presyncope or syncope using different doses of isoproterenol and different tilt angles 
found that the specifity of the head up tilt test was ninety two percent when performed 
at sixty degrees angle, ninety two per cent at seventy degrees too and eighty per cent 
at eighty degrees angle. Addition of a low dose of isoproterenol decreased the 
specifity marginally at sixty and seventy degrees to 88 per cent. But it was decreased 
substantially at eighty degrees to sixty per cent. With head up tilt test at seventy 
degrees the specifity was ninety six  per cent with low dose isoproterenol infusion, 80 
per cent with 3 mcg per minute infusion and 44 per cent with 5 mcg per minute 
infusion. The specificity of the test was high when the tilt was sixty or seventy degrees 
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with the isoproterenol infusion or with a low dose proterenol infusion. But the 
specificity of the tilt test was significantly reduced at eighty degrees and with low 
dose isoproterenol or at seventy degrees with infusion rate of isoproterenol of 3 or 5 
mcg per minute. So, data from this study showed that head up tilt testing at sixty or 
seventy degrees without or with low dose isoproterenol can provide a specificity 
ranging from eighty eight per cent to ninety two per cent.(32) 
A study was done to evaluate a prolonged sixty degrees head up tilt testing to 
diagnose neurally mediated syncope. Of the seventy one patients with unexplained 
recurrent syncope who underwent sixty minutes of head up tilt test at sixty degrees of 
tilt, fifty three (75 per cent) had a positive head up tilt test. Similar angle and duration 
of tilting in twenty seven control subjects had positive response in only two patients 
(seven per cent).  
Of the patients with a positive response, twenty per cent of the patients did not have 
the abnormal response on repeat head up tilt testing. The angle of tilt was also found 
to be important. With a sixty degree tilt, positive response was observed in seventy 
five per cent of the unexplained syncope patients but this reduced to only thirty per 
cent at 45 degrees of tilt. This shows that tilting at less than sixty degrees will result in 
false negative outcome in evaluation of patients with unexplained syncope. This study 
also indicated that a high number of false positive results will be expected with short 
periods of tilting and a duration of forty five minutes was selected.(33) 
In a group of seventy three patients with unexplained syncope after clinical, 
cardiovascular and neurological assessment, a head up tilt test was done with 
isosorbide dinitrate and ten asymptomatic subjects were chosen as controls. They were 
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tilted at sixty degrees for thirty minutes without isosorbide dinitrate  and if no 
symptoms occurred, 1.25 mg of the drug was given sublingually and the test was 
continued for fifteen more minutes. Fourteen of the subjects (19.2 per cent) had 
syncope during the drug free phase and after administration of isosorbide dinitrate 
another 28 patients (38.3 per cent) had syncope. All the controls had negative results. 
So, the positive rate of head up tilt test with isosorbide dinitrate was 57.5 per cent and 
specificity was 100 per cent according to this study.(34) 
Another study was done to look at the value of isosorbide dinitrate before 
isoproterenol tilt test for the diagnosis of neurocardiogenic syncope and included 
ninety six patients with unexplained syncope and seventy two healthy volunteers as 
controls. When compared with isoproterenol infusion, test done with isosorbide 
dinitrate isoproterenol caused a higher decline in the systolic and mean blood 
pressures. The duration and the time for induction of syncope were significantly 
shorter in the isosorbide isoproterenol group than in isoproterenol group. The control 
subjects rarely had a positive response to isosorbide dinitrate isoproterenol test. So, 
the positive rate, predictive accuracy and specificity were all higher in the isosorbide 
isoproterenol group when compared to the isoproterenol group.(35) 
A comparative study of diagnostic accuracy of sublingual nitroglycerin and low dose 
isoproterenol was done in seventy one patients with unexplained syncope without 
organic heart disease and thirty control subjects who were asymptomatic. In this 
study, with sublingual nitroglycerin, the positivity rate was forty nine per cent, 
specificity was ninety per cent and predictive accuracy was sixty two per cent. With 
intravenous isoproterenol, the positivity rate was forty one per cent, specificity was 86 
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per cent and predictive accuracy was fifty five per cent. These were comparable 
results. There was also a high concordance of results and identical mean duration. 
But sublingual nitroglycerin is better tolerated, simpler and better tolerated, does not 
require intravenous cannulation and does not have significant adverse effects. So, it is 
favourable for initial evaluation of patients with unexplained syncope.(36) 
 
The duration of the tilt test is also important. Conventional head up tilt test is 
performed by a drug free phase of forty five minutes and if it is negative, 400 mcg 
nitroglycerin spray is administered. However, in a shortened head up tilt test, passive 
standing at sixty degrees without drug is followed by 400 mcg of nitroglycerin spray 
sublingually if the drug free tilt test is negative. One study revealed  equivalent 
positivity rate in both the approaches with reduction in the time taken for the test by 
forty five per cent in the shortened head up tilt test. A high specificity was also 
confirmed in the shortened test in elderly patients. It was concluded that the shortened 
nitroglycerin head up tilt test was preferable to the more time consuming conventional 
head up tilt test.(37) 
 
SYNCOPE IN THE ELDERLY: 
Syncope has a higher incidence in elderly and has a higher health service use and 
serious adverse events compared to the young. This is largely due to multiple 
comorbidities, multiple medications, age associated physiological changes and 
cognitive decline. Also, there is a lower threshold for admission in the older patients 
presenting with syncope. 
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In the elderly population, vasovagal syncope is a widely known cause of falls and the 
head-up tilt test is a valuable investigation for diagnosis of vasovagal syncope. In 
older patients, with prolonged orthostatic stress, a chronotropic incompetence is a 
characteristic pathophysiological response. Also, the cerebrovascular, cardiovascular 
and neurodegenerative comorbidities related to the old age influence this 
pathophysiological response.  
A study designed to compare features of syncope in elderly to young patients recruited 
two hundred and ten patients and compared them with one hundred and ninety young 
individuals. A cardiovascular cause was found in 33.8 per cent of elderly as compared 
to 16.8 per cent of young patients, while a non cardiovascular cause was found in 26.7 
per cent of elderly as compared to 37.9 per cent of the young. A prolonged ECG 
monitoring established the diagnosis of syncope in 17 per cent of the elderly but only 
in 8 per cent of the young. Syncope resulted in trauma in 38 per cent of the elderly and 
32 per cent in the young. But the elderly had major trauma more often. Also the two 
year mortality was 26.9 per cent in the elderly and 8.3 per cent in the young. In 
patients who had a non cardiovascular cause of syncope or an unknown cause of 
syncope, older age, male gender and a history of congestive cardiac failure were found 
to be important prognostic factors.(38)  
It was found in a study that the clinical features of neurally mediated syncope are 
different in older patients and the frequency of symptoms during the prodromal and 
recovery phase are less. Thus, in the older age group, the clinical manifestation of 
cardiac and neurally mediated syncope are similar. This finding, along with an 
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increased prevalence of heart disease in the elderly reduces the utility of a history in 
differentiating among the two causes of syncope.(39) 
The change in the clinical pattern of syncope with age can be due to several 
mechanisms listed as follows: 
a. Age related decline in the parasympathetic activity 
b. Decline in the beta- adrenergic cardioaccleratory response with age 
c. A smaller increase in the epinephrine in the circulation when upright(39) 
 
HUTT TEST IN THE ELDERLY 
 
Even though the elderly do not have structural heart disease, there is a higher 
probability of borderline response to carotid sinus massage or sinus bradycardia. If 
vasovagal syncope is not diagnosed in these patients as the cause of syncope, it makes 
clinicians consider pacemaker implantation. So, diagnosing vasovagal syncope is 
important in the elderly. 
In the elderly population, the safety of the head-up tilt test was assessed in an 
observational study in which, one thousand four hundred and ninety five drug free and 
four hundred and seventy four glyceryl trinitrate provoked head-up tilt tests were 
studied. Head-up tilt test was found to be safe in elderly even for people in the ninth 
decade of their age. The neurological and cardiovascular adverse events were 
negligible and the patients who had syncope recovered fully after the test. None of the 
patients required admission.(40) 
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The use of sublingual nitroglycerin during head up tilt test was also studied in patients 
more than sixty years of age and its specificity and sensitivity was compared with 
isoproterenol. It was found that in patients with a history of syncope, the ability to 
develop a vasovagal response and a positive tilt test with isoproterenol declines with 
age. But in the same group of patients, sublingual administration of niitroglycerin 
significantly increased the sensitivity of tilt table test and was well tolerated.(41) 
In another study, the effects of age on the outcome of head up tilt test was also studied 
in patients of varying ages undergoing evaluation for unexplained syncope. The 
subjects were subdivided into four groups as follows: less than forty years, forty to 
sixty four years, sixty five to seventy nine years and eighty years and above. 
During the tilt table testing, syncope occurred in forty seven per cent of the patients. 
Also, there was a decline in the positivity of tilt table test with age. It was fifty five per 
cent in the group of less than forty years age, fifty per cent in the age group forty to 
sixty four, thirty nine per cent in sixty five to seventy nine years and twenty three per 
cent in subjects more than eighty years of age. This age related decline was seen in 
both males and females.(42) 
Elderly have more comorbidities and poly pharmacy is common. There is a possible 
effect of these two factors also on the occurrence of syncope.  Antihypertensives like 
beta blockers, calcium channel blockers, nitrates and antidepressants have all been 
shown to cause postural drop in blood pressure.  A study was done in one hundred and 
sixty four elderly subjects to assess the influence of medication use and comorbidities 
on the outcome of the tilt table test in patients in the geriatric age group. In this study, 
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the variables assessed were age, gender, comorbid conditions of diabetes mellitus, 
hypertension, cerebrovascular disease and chronic heart failure. Medications included 
were angiotensin converting enzyme inhibitors, beta blockers, calcium channel 
blockers, diuretics, digoxin, opioids, benzodiazepines, antidepressants, digoxin and 
non steroidal anti-inflammatory drugs. It showed that the tilt table test outcome was 
uninfluenced by gender, age, long term medications or comorbidities. Although a long 
term calcium channel blocker intake was associated with transient orthostasis and 
drop in blood pressure but it did not influence the heart rate or the outcome of tilt table 
test.(43) 
The summary of principal recommendations for the technique of tilt table testing is as 
follows: 
a. The laboratory should be quiet with dim lighting, comfortable temperature and 
a supine equilibration period of 20 to 45 minutes should be allowed.  
b. Prior to the procedure, the patient should be fasting overnight or for several 
hours and follow up studies should be done at similar times of the day. 
c. A minimum of three ECG leads should be recorded continuously and blood 
pressure should be recorded using least invasive means. 
d. A foot board should be there for support and smooth and rapid transitions up 
and down transitions should be made. 
e. The acceptable tilt angle is sixty to eighty degrees, seventy degrees being the 
most common. 
f. Initial drug free tilt should be done for thirty to forty five minutes and the 
duration of pharmacological provocation depends on the drug used 
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g. The pharmacologic provocation includes isoproterenol, nitroglycerin and 
edrophonium. 
h. A laboratory technician or nurse who is experienced in tilt table technique and 
cardiac laboratory procedures should supervise the procedure. Also, a 
physician should be in attendance or immediately available.(31) 
 
SUMMARY OF PRINCIPAL INDICATIONS FOR TILT TABLE TEST 
EVALUATION: 
 
Tilt table testing is warranted if: 
a. Recurrent or single episode (in a high risk patient like surgeons, pilots, vehicle 
drivers) of syncope and there is no structural disease, or there is structural 
cardiac disease but other causes of syncope have been excluded by appropriate 
tests. 
b. Further evaluation of patients in whom a cause has been found (eg. Asystole, 
AV block) but susceptibility to vasovagal syncope can affect treatment plans. 
c. Part of evaluation of exercise induced/associated syncope. 
A difference of opinion exists regarding usefulness of tilt testing in the following 
scenarios: 
a. Differentiating seizures from convulsive syncope. 
b. Evaluation of patients, especially geriatric patients presenting with recurrent 
falls 
c. Assessment of recurrent dizziness or presyncope. 
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d. Follow up of patients with neurocardiogenic syncope to assess therapy 
e. Evaluation of syncope in patients with dysautonomia or peripheral neuropathy. 
A tilt table testing is not warranted in the following cases: 
a. Single episode of syncope without injury and not in high risk setting with 
clinical features of vasovagal syncope 
b. Cases in which an alternative cause has been found and demonstration of 
neurally mediated syncope will not change treatment plans.(31) 
 
Relative contraindications to tilt table test in syncope are when syncope occurs in the 
setting of the following: 
a. Clinically severe left ventricular outflow tract obstruction 
b. Critical mitral stenosis 
c. Critical cerebrovascular stenosis 
d. Critical proximal coronary artery stenosis 
(31) 
MANAGEMENT OF VASOVAGAL SYNCOPE: 
 
Vasovagal syncope is usually benign and can have frequent episodes interspersed with 
long periods without recurrences.  
CONSERVATIVE MANAGEMENT: 
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Among patients with vasovagal syncope, about two thirds have a prodrome at the 
onset and it has been seen that physical manoeuvres to increase the venous return may 
abort the syncope. In Italy, for  patients prone to have fainting spells, the general 
practitioners of the older generation advised to carry a wooden egg and to grip it 
forcefully when they felt that a faint was imminent. Later, a rubber ball was devised 
for the same purpose. 
A constant and early symptom of vasovagal syncope is muscle tone inhibition causing 
muscle weakness. During a faint, as much as one and a half litres of blood is diverted 
to the blood vessels of the muscles and so, muscle contractions can potentially abort 
or postpone a vasovagal episode.(44) 
So, an isometric contraction of large muscles causes a significant rise in the blood 
pressure during the phase when the patient is experiencing the syncopal prodrome and 
feels syncope is imminent may avoid or delay the syncope. 
A study was done to assess the effectiveness of muscle tensing and leg crossing to 
control or abort the faints and it included twenty one patients with a history of 
recurrent syncope and for all of whom routine head up tilt test was positive. 
Instruction was given to perform muscle tensing and leg crossing for at least half a 
minute at the onset of a head up tilt induced impending syncope while the heart rate 
and blood pressure were being monitored. It was found that muscle tensing and leg 
crossing was effective in combating the presyncopal symptoms as well as aborting or 
delaying the syncopal episodes.(45)  
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Another study evaluated the effects of three physical manoeuvres on vasovagal 
syncope in twenty one head up tilt test positive patients. The tree manoeuvres were leg 
crossing with muscle tensing, squatting and handgrip and their effect was compared 
on preventing or aborting a vasovagal episode. It was found that leg crossing with 
muscle tensing and squatting significantly improved the hemodynamics during head 
up tilt testing but hand grip did not. The results from this study suggested that leg 
crossing and squatting can be preventive techniques for patients with vasovagal 
syncope.(46) 
A prospective multicentre randomized controlled clinical trial including two hundred 
and twenty three patients with recurrent vasovagal syncope with recognizable 
prodrome showed that the group trained in physical counter pressure manoeuvres had 
a significantly lower burden of median yearly syncope compared to the control group 
over a mean follow up period of fourteen months. The actual relative risk reduction 
was thirty nine per cent and there were no adverse events.(47) 
 
PHARMACOLOGICAL MANAGEMENT: 
 
Low risk patients who have had only one episode of syncope should be reassured and 
no further investigation is required. If the diagnosis of neutrally mediated syncope or 
orthostatic hypotension is made, the treatment is mostly supportive. But if the 
symptoms are frequent or severe, pharmacotherapy is required.(48) 
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 The first step in the management of vasovagal syncope in the elderly is drug review 
and decreasing the number of medications that can cause drop in blood pressure. 
a. BETA BLOCKERS:  
beta blockers were the initial treatment since they were thought to decrease the 
effects of circulating catecholamines. But the randomized controlled clinical 
trials do not support their efficacy and they have been shown to be no more 
effective than placebo. One of these studies was done in fifty patients with 
recurrent episodes of vasovagal syncope, each having had at least two episodes 
of syncope in the last year. They were randomized into two groups, one 
receiving atenolol and the other receiving placebo and they were followed up 
for a year thereafter with the primary end point as the first recurrence of 
syncope. It was found that the recurrence of syncope in the patients who were 
highly symptomatic was no different among the two groups.  
Another prospective randomized crossover study which evaluated the effect of 
nadolol, propranolol and placebo on the recurrence of syncope and the well 
being of thirty patients  with syncope found that there was no difference in the 
efficacy of the two drugs and placebo.(49) 
 
b. FLUDROCORTISONE :  
a trial compared fludrocortisone with placebo in patients with recurrent 
vasovagal syncope and it only showed a trend towards benefit with treatment. 
So, due to lack of evidence, it may be reasonable to use it in patients who have 
severe symptoms.(2) 
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c. MIDODRINE: 
 It is a peripherally acting alpha agonist which causes arterial and venous 
vasoconstriction and has been approved for the treatment of orthostatic 
hypotension. In an observational study, a daily 22mg dose of midodrine was 
found to be effective in improving the symptoms in patients having vasovagal 
syncope recurrences, was easy to use and generally well tolerated. This study 
also confirmed the ability of the drug to reduce the orthostatic changes in the 
blood pressure, which is expected to reduce the vulnerability to vasovagal 
syncope. This is because the more the difference between supine and upright 
blood pressures, greater is the susceptibility to vasovagal syncope. Midodrine 
significantly minimized orthostatic stress by arterial and venous 
constriction.(50)  
Another randomized controlled study was done to assess the usefulness of this 
drug in patients having severely symptomatic neurocardiogenic syncope in 
sixty one patients who were randomly divided to receive either midodrine or 
fluid, salt tablets and counselling and it was found to have a significant benefit 
in neurocardiogenic syncope.(51) 
d. SEROTONIN TRANSPORT INHIBITORS: 
 Apart from the autonomic nervous system, the serotonergic system may also 
be involved in the pathophysiology of vasovagal syncope.  Serotonin reuptake 
inhibitors like sertraline and fluoxetine have been used for the treatment of 
syncope. In a study, ninety six patients with recurrent vasovagal syncope were 
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randomly divided to receive fluoxetine, propranolol or placebo and a six month 
follow up was done. It was found to be equivalent to placebo and propranolol 
in the treatment of the condition.(52) 
Another randomized controlled double blind placebo controlled study to study 
the effects of paroxetine on refractory vasovagal syncope done in sixty eight 
patients who had recurrent syncope with positive head up tilt test and had failed 
to respond to beta blockers, vagolytics and minerallocorticoids  or had poorly 
tolerated these therapies. In the follow up period of two years the recurrence of 
syncope in the placebo group was 52.9 per cent while in the paroxetine group it 
was 17.6 per cent. The number of syncopal attacks also reduced significantly in 
the Paroxetine group.(53) 
 
A meta analysis was done which showed that alpha adrenergic agonists were effective 
in preventing recurrence of vasovagal syncope. Beta blockers were not effective in 
comparison to the non pharmacological management. The tilt training had no effect 
when only randomized controlled studies were taken into consideration.(54) 
PACEMAKER TREATMENT FOR VASOVAGAL SYNCOPE: 
 
A pacemaker can prevent extreme bradycardia and asystole which can be seen in 
many patients with syncope. The rate drop response feature of a pacemaker can sense 
an abrupt drop in the heart rate of the patient and provides a high rate dual chamber 
pacing. This response can augment the cardiac output which occurs prior to a 
vasovagal syncope and thus can prevent the episode. In a study, patients with more 
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than six episodes of syncope in their lifetime and with a tilt table test induced syncope 
or presyncope with relative bradycardia were randomized into two groups one of 
which received dual chamber pacemaker and the other did not. A marked relative risk 
reduction of 85.4 per cent was found in the patients who were treated with a 
pacemaker. It was thus concluded that a dual chamber pacing reduced the likelihood 
of syncope in patients with recurrent vasovagal episodes.(55) 
Another prospective multi center randomized controlled study was done to test the 
hypothesis that a pacemaker implantation reduces the risk of recurrent syncope 
compared with no pacemaker. This study showed that a dual chamber permanent 
pacemaker markedly reduced the chance of recurrence of syncope in patients who had 
severe cardioinhibitory response to tilt table testing to about one per cent per year, the 
benefits of which were maintained for more than five years. But if the patients were 
untreated, fifty per cent of the patients would have a recurrence within a year and 
about two thirds within five years.(56) 
 TILT TRAINING: 
 
Tilt training is based on the notion that an adaptation to an upright posture occurs only 
when the orthostatic stress is present for a longer duration and it disappears when 
there is long term immobilization or lack of gravity. 
Apart from pharmacological therapy and pacemaker implantation, tilt table training is 
another promising method in treatment of patients with vasovagal syncope. In a study 
to assess the efficacy of tilt training in patients with vasovagal syncope, forty patients 
with recurrent vasovagal syncope received tilt training using the tilt table. As per the 
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VASIS classification, a type 1 or mixed response was found in seventeen patients, 
type 2 or cardioinhibitory response was found in twenty two patients and a type 3 or 
vasodepressive response was found in one patient. It was found that in the patients 
with vasovagal syncope, tilt table training was effective in a majority and a cessation 
of this training was associated with a recurrence of positive tilt table test inspite of a 
lack of syncopal episodes.(57) 
A prospective randomized trial was done in eighty two patients who presented with 
recurrent vasovagal syncope and had positive head up tilt tests who were randomized 
to conventional therapy versus conventional therapy with additional head up tilt 
training sessions.  During a follow up of one year, the syncope recurrence was fifty six 
per cent in the control group versus thirty per cent in the tilt training group but it was 
found to be statistically insignificant. Also the time to first recurrence and the 
frequency of syncope was also found to be similar in both the groups. But during the 
follow up period the rate of syncope was higher in the control group as compared to 
the tilt trained group in patients with vasodepressor type of syncope. So, as per this 
study, the tilt training was not found to be able to affect vasovagal syncope recurrence 
except for the vasodepressor type of syncope.(58) 
Patient education is the mainstay of syncope treatment. Patients should be advised to 
avoid the predisposing conditions if any such as stress, dehydration, very warm 
environment, consumption of alcohol and tight clothing. Also, anxiety about the 
condition, coping skills are also paramount. The patient should be reassured that it is a 
benign condition.(25) 
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METHODOLOGY: 
 
SETTING: 
 
This study was done in the Geriatrics department of the Christian Medical College, 
Vellore. Christian Medical College, Vellore is a three thousand bedded tertiary care 
hospital in the Vellore district in Tamil Nadu. It has a daily out patient load of around 
six thousand.  
 
STUDY DESIGN: 
 
It was a prospective cohort study done in forty four elderly patients. The study and 
methodology was approved by the institutional review board of Christian Medical 
College, Vellore (IRB MIN NO. 10573 dated 8/3/2017). 
 
STUDY POPULATION: 
 
Subjects aged sixty years or more were included from the outpatient departments of 
Geriatrics and Cardiology. The patients were recruited according to the following 
eligibility criteria: 
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INCLUSION CRITERIA: 
 
1. Subjects 60 years and above undergoing HUTT in Christian Medical College Vellore. 
2. Subjects capable of giving informed consent. 
3. Hemodynamically stable and ambulant patients. 
EXCLUSION CRITERIA: 
 
      Fragility/ inability to stand  
Lower extremity fractures  
Severe anemia  
Recent stroke (within six months)  
Recent myocardial infarction (within six months)  
Severe proximal cerebral or coronary arterial disease  
Critical mitral or aortic stenosis  
End-stage renal failure  
Severe heart failure 
Advanced malignancy 
Dementia 
Autonomic dysfunction – Orthostatic hypotension 
 
52 | P a g e  
 
SUBJECT ENROLLMENT: 
 
After fulfilling the inclusion and exclusion criteria, the eligible patients were informed 
about the nature of study and their specific role in it. The patients were recruited as and 
when they came to the HUTT room in the cardiology ward of Christian Medical College, 
Vellore. The HUTT would be ordered on OPD basis by the various departments for 
evaluation of syncope. An informed consent was taken and the patients who were willing 
to participate in the study and signed an informed consent were recruited. 
 
MATERIALS AND METHODS: 
 
SAMPLE SIZE 
 
For the sample size calculation, the statistical inputs are taken from the following 
reference article : “Nitrate-Potentiated Head-Up Tilt Testing (HUTT) Has a Low 
Diagnostic Yield in Patients with Likely NCS Nunzia R. Petix, Attilio Del Rosso, 
Rafaello Furlan, Vincenzo Guarnaccia, and Andrea Zipoli Arrhythmology Section – 
Cardiology Department, San Giuseppe Hospital, Empoli (FI), Italy; and †Internal 
Medicine Department, Istituto Clinico Humanitas, University of Milan, Rozzano (MI), 
Italy 
          The sample size is calculated using Master software version 2.0.  
Statistical inputs: 
 Comparison in Typical History: 
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            HUTT Positive = 64% 
 
            HUTT Negative = 36% 
Comparison in Atypical History: 
            HUTT Positive = 37% 
            HUTT Negative = 63% 
Based on the sample size calculation for both (typical/atypical features) comparison 
with HUTT outcomes, the maximum number will be considered as total number of 
patients for the study. 
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The study requires totally 114 patients [Group 1 (n1 = 57) and Group 2 (n2 = 57)] to 
make the results of this study statistically significant. 
 
The patients presenting with a history of syncope to the Cardiology and Geriatrics 
departments in Christian Medical College, Vellore from May 2017 to October 2017. A 
detailed collection of data was done for all the subjects in the following areas as per the 
proforma. 
1. Demographic profile of the patient 
2. Socioeconomic status of the patient based on the Urban Kuppuswamy socioeconomic 
scale 
3. The history of syncope was taken and based on the prodromal symptoms, the subjects 
were divided in those having typical syncope and atypical syncope. The duration and 
number of episodes was also noted. 
4. A history was also taken about a prodromal symptoms if any and the subjects were 
specifically asked about the history of warmth, nausea, sweating, light headedness, 
blurred vision, dizziness, epigastric discomfort and hot flashes. 
5. A history of triggers was also taken and the subjects were asked if the syncope was 
triggered by emotional distress, orthostatic stress, pain, whether it was situational and 
occurred during cough, micturition, defecation or swallowing or exertion or 
instrumentation.  
6. They were also asked the position in which most of their syncopal episodes occurred. 
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7. An account of the comorbidities was also taken and the patients were asked whether 
they suffered from hypertension, diabetes mellitus, ischemic heart disease, whether 
they had a history of cerebrovascular accident, dyslipidemia or chronic obstructive 
pulmonary disease. 
8. A Charlson comorbidity score was also calculated and divided into low, medium, 
high and very high. 
9. The medications were also noted and the use of specific medications was inquired 
like ACE inhibitors/Angiotensin receptor blockers, beta blockers, calcium channel 
blockers, diuretics, benzodiazepines and antidepressants. 
10. A mini COG test was done in which, the subjects were asked to recall 3 words and 
draw a clock. If they could recall all three words, the mini COG test was considered 
negative. Also, if they could recall one or two words but were able to draw the clock 
correctly, the test was considered negative. However, if they could recall two or lesser 
words and had an abnormal clock drawing, the test was considered positive for 
cognitive impairment. 
11. Their functional status was also assessed by using the Barthal‟s index. 
12. The hand grip was checked using a Jamar Hand dynamometer. In a seated position 
with shoulder adducted and neutrally rotated, elbow flexed at ninety degrees, forearm 
in neutral position and wrist between zero and thirty degrees dorsiflexion and 
between zero and fifteen degrees ulnar deviation. Three trials in the dominant hand 
were given with a two minute break and the final score was an average if the three 
trials. 
13. Examination of the pulse was done and rate and rhythm were noted. 
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14. A baseline blood pressure was checked in the supine position and in the standing 
position at one and three minutes and change in blood pressure was assessed. If in the 
standing position, the systolic blood pressure reduced by 20 mm Hg or more and/or 
the diastolic blood pressure reduced by 10 mm Hg or more, it was defined as a 
orthostatic fall in blood pressure. 
15. A clinical examination of the cardiovascular system was done and clinical features of 
left heart failure were noted, if any. 
16. After this, a head up tilt test was performed. In this, the patient was asked to report to 
the HUTT room in the cardiology ward, where, the patient was strapped to the HUTT 
table and a nurse started an intravenous line and connected the subject to monitors to 
record non invasive blood pressure, heart rate and continuous ECG. After five 
minutes of lying supine, the table was quickly turned to raise the body to a head up 
position at seventy degrees, simulating a change from lying down to standing up. The 
table then remained upright for 20 minutes while the subject‟s heart rate, blood 
pressure and ECG were monitored. After 20 minutes, 5 mg of sublingual sorbitrate 
was given and the table was kept upright for another 20 minutes. The test was 
considered positive if there was reproduction of the syncope and the patient had a 
transient loss of consciousness. In this case, the table was immediately made flat. 
Resuscitation kit and atropine injections were kept ready and the patient was 
constantly monitored by a doctor throughout the test. The principal investigator 
(myself) either assisted in or performed the HUTT test. Based on the drop in heart 
rate, and blood pressure, the HUTT Positive tests were classified according to the 
classification of the Vasovagal Syncope International Study (VASIS) : 
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 1) Mixed type: Heart rate falls at the time of syncope, but the ventricular rate does not fall to 
less than 40 beats per minute , or falls to less than 40 beats per minute for less than 10 
seconds with or without asystole of less than 3 seconds. Blood pressure falls before the heart 
rate falls.  
2) Cardioinhibitory type: Type IIA:  Heart rate falls to a ventricular rate less than 40 beats per 
minute for more than 10 seconds, but asystole of more than 3 seconds does not occur. Blood 
pressure falls before the heart rate falls.  
Type IIB: Asystole occurs for more than 3 seconds. Heart rate fall coincides with or precedes 
blood pressure fall. 
3) Vasodepressor type: The heart rate does not fall more than 10% from its peak value at the 
time of syncope 
17.  Basic investigations – blood tests and ECG were done, and ECHO and a Holter 
monitoring were done for most patients as part of the basic work up for syncope. 
Additional investigations, like EEG, MRI etc were ordered by the treating physician if 
required. The management as advised by treating physician was collated from the 
medical report or the out patient record. The patients will be followed up telephonically 
after six months following their OPD visit .Details of further investigations ordered (such 
as electrophysiologic studies) and the final cause of syncope identified was documented.  
The results were statistically analysed. 
 
DATA INTEGRATION AND ANALYSIS: 
 
58 | P a g e  
 
1) Analysis of HUTT response in typical versus atypical history of syncope in elderly 
population in our hospital 
2) Analysis of occurrence of prodromal symptoms in syncope. 
3) Analysis of comorbidities and medications with respect to type of syncope and HUTT 
response. 
4) Analysis of association of HUTT response with cognition and hand grip strength. 
5) Analysis of association of type of syncope with HUTT response 
6) Association of ECG and Holter with type of syncope and HUTT response 
 
RESULTS 
 
A total of 44 patients were recruited to participate in the study. The sample size could not be 
reached. 
DEMOGRAPHY 
 
AGE: 
 
Of a total of 44 patients recruited in the study thirty four patients were in the age group of 
sixty to seventy years and ten patients were in the age group seventy to eighty years. 
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Age of the subject (years) Head up tilt test   
  negative positive    
60-70 25 (83.33) 9 (64.29) 0.160 
70-80 5 (16.67) 5 (35.71) 
 
In the age group of sixty to seventy years, 73.52 per cent patients with history of syncope had 
negative head up tilt test while in the age group of seventy to eighty years, 50 per cent were 
HUTT negative. 
Age of the subject (years) History typical of vasovagal syncope   
34 
10 
Age 
60-70 71-80
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  YES  NO    
60-70 21 (77.78) 13 (76.47) 0.920 
70-80 6 (22.22) 4 (23.53) 
 
61.76 per cent of the patients in the age group of 60-70 years presented with a history 
of typical syncope and sixty per cent of patients in the 70-80 years age group had a 
history of typical syncope. 
 
 
 
SEX: 
 
Sex of the subject Typical syncope Atypical syncope Total  
Male  21 (77.78%) 17 (22.22) 38 (86.36%) 
Female  6   (100%) 0 6   (13.64%) 
P= 0.036 
6 of the 44 patients were females and all of them had presented with a history of 
typical syncope. Thus, in this study, female gender had significant association with 
typical syncope. 
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Sex of the subject HUTT negative HUTT positive Total 
Male 25 (85.33%) 13 (92.86%) 38 (86.36%) 
Female 5   (16.67%) 1   (7.14%) 6   (13.64%) 
P= 0.391 
There was no association of gender with HUTT positivity. 
PRODROMAL SYMPTOMS: 
WARMTH 
The following table evaluates association of a history of warmth with the type of syncope. 
History of warmth Typical syncope Atypical syncope Total 
Yes 8     (29.63%) 1    (5.88%) 9 
No 19   (70.37%) 16  (94.12%) 35 
P= 0.057 
38 
6 
Sex  
male
female
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As per the table, the prodrome of warmth approached significant association with 
typical syncope. 
The table below evaluates association of history of warmth with HUTT positivity  
History of warmth HUTT positive HUTT negative Total 
Yes 7    (23.33%) 2    (14.29%) 9     (20.45%) 
No 23  (76.67%) 12  (85.71%) 35   (79.55%) 
P= 0.488 
It was found that 23.33 per cent of the patients who were HUTT positive had a 
prodrome of warmth and 14.29 per cent of HUTT negative patients had it. But this too 
was statistically insignificant. 
NAUSEA 
The table below evaluates association of history of nausea with type of syncope 
History of nausea Typical syncope Atypical syncope Total 
Present 4    (14.81%) 1    (5.88%) 5    (11.36%) 
Absent 23  (85.19%) 16  (94.12%) 39  (88.64%) 
P=0.363 
It was found that in all the patients with syncope, 11.36 per cent had a history of 
nausea but there was no statistically significant difference between HUTT positive 
and negative patients. 
The following table evaluates HUTT positivity and history of nausea as prodrome of 
syncope: 
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History of nausea HUTT negative HUTT positive Total  
Present  4   (13.33%) 1   (7.14%) 5   (11.36%) 
Absent  26 (86.67%) 13 (92.86%) 39 (88.64%) 
P= 0.547 
A total of 11.36 per cent patients had a history of nausea but there was no statistically 
significant difference between HUTT positive and negative groups. 
SWEATING 
 
The table below evaluates association between a history of sweating and a typical 
history of syncope: 
History of sweating Typical syncope Atypical syncope Total  
Present  12   (44.44%) 0 12 (27.27%) 
Absent  15   (55.56%) 17  (100%) 32 (72.73%) 
P= 0.001 
It was found that a history of sweating was significantly associated with typical 
syncope.  44.44 per cent of subjects with a history of typical syncope had sweating as 
a prodrome but none of the patients with atypical syncope had sweating. 
The following table evaluates association of sweating as a prodrome with HUTT 
positivity: 
History of sweating HUTT negative HUTT positive total 
Yes 9   (30%) 3   (21.43%) 12  (27.27%) 
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No 21 (70%) 11 (78.57%) 32  (72.73%) 
P= 0.552 
It was found that sweating was present as a prodrome in 30% of patients with HUTT 
negativity and 21.43% patients with HUTT positivity and it was insignificant. 
LIGHT HEADEDNESS 
 
The table below evaluates association of typical syncope with a history of light 
headedness 
light headedness Typical syncope Atypical syncope total 
yes 8   (29.63%) 0 8   (18.18%) 
no 19 (70.37%) 17  (100%) 36 (81.82%) 
P= 0.013 
There was a significant association between a history of typical syncope with history 
of light headedness. None of the patients with atypical syncope had a history of light 
headedness in the study. 
 
History of light 
headedness 
HUTT negative HUTT positive Total 
Yes 6   (20%) 2   (14.29%) 8   (18.18%) 
No 24 (80%) 12 (85.71%) 36 (81.82%) 
P= 0.647 
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The above table shows no significant association of HUTT positivity with a history of 
light headedness. 
BLURRED VISION 
The two tables below evaluate association of typical and atypical syncope and HUTT 
positivity with the prodrome of blurred vision: 
Blurred vision Typical syncope Atypical syncope Total 
yes 19  (70.37%) 1   (5.88%) 20  (45.45%) 
no 8    (29.63%) 16 (94.12%) 24  (54.55%) 
P= 0.00 
 
Blurred vision HUTT negative HUTT positive total 
yes 15  (50%) 5   (35.71%) 20  (45.45%) 
no 15  (50%) 9   (64.29%) 24  (54.55%) 
P= 0.375 
The above tables show that although there is a significant association of a history of 
blurred vision with typical syncope, its association with HUTT positivity is 
insignificant. 
DIZZINESS 
The following two tables evaluate the association of a history of dizziness with typical 
and atypical syncope and HUTT positivity: 
History of dizziness Typical syncope Atypical syncope Total 
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yes 21  (77.78%) 2   (11.76%) 23  (52.27%) 
no 6    (22.22%) 15 (88.24%) 21  (47.73%) 
P= 0.000 
History of dizziness HUTT negative HUTT positive Total 
yes 17  (56.67%) 6   (42.86%) 23  (52.27%) 
no 13  (43.33%) 8   (57.14%) 21  (47.73%) 
P= 0.393 
The above tables show that while the history of dizziness is significantly associated 
with typical syncope, it does not have a significant association with HUTT positivity. 
 
EPIGASTRIC DISCOMFORT AND HOT FLASHES: 
A prodrome of epigastric discomfort was not seen in any of the patients. Also, only 
one patient with typical syncope had Hot flashes as a prodrome to syncope and the 
HUTT test was negative for the patient. Thus, these two symptoms did not have a 
significant association with either typical syncope or HUTT positivity. 
 
TRIGGERS: 
EMOTIONAL DISTRESS 
 
The two tables below evaluate association of a history of emotional distress with 
Typical and atypical syncope and HUTT positivity: 
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History of 
emotional distress 
Typical syncope Atypical syncope total 
yes 1  (3.7%) 1  (5.88%) 2  (4.55%) 
no 26 (96.3%) 16 (94.12%) 42 (95.45%) 
P= 0.736 
History of 
emotional distress 
HUTT negative HUTT positive total 
yes 1   (3.33%) 1   (7.14%) 2   (4.55%) 
no 29 (96.67%) 13 (92.86%) 42 (95.45%) 
P=0.572 
The above tables show that no significant association was found between a history of 
emotional distress with either typical syncope or HUTT positivity. 
ORTHOSTATIC STRESS 
 
The following  two tables look at association of orthostatic stress with typical syncope 
and HUTT positivity 
Orthostatic stress Typical syncope Atypical syncope total 
yes 15  (55.56%) 3   (17.65%) 18   (40.91%) 
no 12   (44.44%) 14 (82.35%) 26   (59.09%) 
P= 0.013 
Orthostatic stress HUTT negative HUTT positive total 
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yes 12  (40%) 6  (42.86%) 18  (40.91%) 
no 18  (60%) 8  (57.14%) 26  (59.09%) 
P=0.898 
There was a significant association of orthostatic stress with typical syncope but not 
with HUTT positivity. 
PAIN AND INSTRUMENTATION 
 
None of the patients in this study had pain or instrumentation as a triggering factor for 
syncope. 
SITUATIONAL SYNCOPE 
The following two tables evaluate an association between situational syncope with 
typical presentation and HUTT positivity: 
Situational  Typical syncope Atypical syncope Total  
yes 1   (3.7%) 1   (5.88%) 2   (4.55%) 
no 26 (96.3%) 16 (94.12%) 42 (95.45%) 
P= 0.736 
Situational  HUTT negative HUTT positive total 
yes 1   (3.33%) 1   (7.14%) 2   (4.55%) 
no 29 (96.67%) 13 (92.86%) 42 (95.45%) 
P= 0.572 
The above two tables show that there were only two cases of situational syncope, one 
of which presented as a typical syncope. HUTT was positive for one and negative for 
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the other patient having a history suggestive of situational syncope. Also there was no 
significant association between a history of situational syncope with typical syncope 
or HUTT positivity. 
EXERTION 
 
The two tables below looks at association of exertion with typical syncope and HUTT 
positivity: 
Exertion  Typical syncope Atypical syncope total 
yes 7   (25.93%) 1   (5.88%) 8   (18.18%) 
no 20 (74.07%) 16 (94.12%) 36 (81.82%) 
P= 0.093 
Exertion  HUTT negative HUTT positive total 
yes 7   (23.33%) 1   (7.14%) 8   (18.18%) 
no 23 (76.67%) 13 (92.86%) 36 (81.82%) 
P= 0.195 
In all, 18.18% of the patients had a history of exertion as a precipitating factor for 
syncope. Although the incidence of exertion as a triggering factor for syncope was 
more in typical syncope, but it was not statistically significant. Also, there was no 
significant association of exertion with HUTT positivity. 
POSITION 
 
The following two tables evaluate an association of typical syncope and HUTT 
positivity with position in which the patient experienced syncope respectively: 
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Position  Typical syncope Atypical syncope Total  
Standing  21   (77.78%) 9    (52.94%) 30   (68.18%) 
Sitting  4     (14.81%) 8    (47.06%) 12   (27.27%) 
Walking 2     (7.41%) 0 2     (4.55%) 
P= 0.046 
 
 
Position  HUTT negative HUTT positive Total  
Standing  20  (66.67%) 10   (71.43%) 30   (68.18%) 
Sitting  8    (26.67%) 4     (28.57%) 12   (27.27%) 
Walking  2    (6.67%) 0 2     (4.55%) 
P= 0.613 
In the above two tables, we see that a majority (68.18%) of the patients had syncope in 
the standing position. There was a statistically significant association of standing 
position with a history of typical syncope but there was no association of HUTT 
positivity with a history of standing position. 
COMORBIDITIES 
HYPERTENSION 
In the following tables, an association between hypertension with typical syncope and 
HUTT positivity is evaluated: 
Hypertension Typical syncope  Atypical syncope total 
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Present  17   (62.96%) 12   (70.59%) 29   (65.91%) 
Absent  10   (37.04%) 5     (29.41%) 15   (34.09%) 
P= 0.603 
Hypertension HUTT negative HUTT positive Total  
Present  17   (56.67%) 12   (85.71%) 29   (65.91%) 
Absent  13   (43.33%) 2     (14.29%) 15   (34.09%) 
P= 0.058 
In all, 29 of the 44 patients (65.91%) had hypertension. There was no association 
between hypertension and a history of typical syncope. Although most of the patients 
who were HUTT positive had hypertension but there was no statistically significant 
association of hypertension with HUTT positivity. 
DIABETES MELLITUS 
 
The two tables below evaluate an association of the presence of diabetes mellitus with 
typical syncope and HUTT positivity: 
Diabetes mellitus Typical syncope Atypical syncope Total  
present 9   (33.33%) 5   (29.41%) 14   (31.82%) 
absent 18 (66.67%) 12 (70.59%) 30   (68.18%) 
P= 0.786 
Diabetes mellitus HUTT negative HUTT positive total 
present 12   (40%) 2    (14.29%) 14  (31.82%) 
72 | P a g e  
 
absent 18   (60%) 12  (85.71%) 30  (68.18%) 
P= 0.088 
The above tables show that 31.82% of the patients were diabetics and no significant 
association of diabetes with typical syncope or HUTT positivity was found in our 
study. 
ISCHEMIC HEART DISEASE 
 
The two tables below evaluate an association of typical syncope and HUTT positivity 
respectively with Ischemic heart disease: 
 
IHD Typical syncope Atypical syncope total 
present 3    (11.11%) 4    (23.53%) 7    (15.91%) 
absent 24  (88.89%) 13  (76.47%) 37  (84.09%) 
P= 0.273 
IHD HUTT negative HUTT positive total 
present 4    (13.33%) 3    (21.43%) 7    (15.91%) 
absent 26  (86.67%) 11  (78.57%) 37  (84.09%) 
P= 0.494 
According to this study, a total of 15.91% of the patients presenting with syncope had 
ischemic heart disease. But a significant association was not found between Ischemic heart 
disease and typical syncope. Likewise, there was no significant association between Ischemic 
heart disease and HUTT positivity. 
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CEREBROVASCULAR ACCIDENT 
 
The following two tables evaluate association of a history of cerebrovascular accident with 
typical syncope and HUTT positivity: 
History of CVA Typical syncope Atypical syncope total 
present 1   (3.70%) 1   (5.88%) 2   (4.55%) 
absent 26 (96.3%) 16 (94.12%) 42 (95.45%) 
P= 0.736 
History of CVA HUTT negative HUTT positive total 
present 1   (3.33%) 1   (7.14%) 2   (4.55%) 
absent 29 (96.67%) 13 (92.86%) 42 (95.45%) 
P= 0.572 
In all, only two patients had a history of Cerebrovascular accident. One of them had typical 
and the other atypical vasovagal syncope. There was no significant association of 
cerebrovascular accident with typical syncope. The HUTT response was positive in one 
patient with history of cerebrovascular accident and negative in the other. This also did not 
show any significant association with HUTT response. 
DYSLIPIDEMIA 
 
The two tables below evaluate the association between dyslipidemia and Typical syncope and 
HUTT positivity: 
Dyslipidemia  Typical syncope Atypical syncope total 
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present 15  (55.56%) 7   (41.18%) 22 (50%) 
absent 12  (44.44%) 10 (58.82%) 22 (50%) 
P= 0.353 
Dyslipidemia  HUTT negative HUTT positive total 
present 12 (40%) 10 (71.43%) 22 (50%) 
absent 18 (60%) 4   (28.57%) 22 (50%) 
P= 0.052 
Half of the patients with syncope were found to have dyslipidemia. However, there was no 
significant association between typical syncope and dyslipidemia. 71.43% patients with 
HUTT positive response had dyslipidemia while 40% of the patients with HUTT negative 
response had dyslipidemia. This association was approaching significance with a P-value of 
0.052 but was not statistically significant. 
COPD 
 
In the following tables, association between COPD and typical syncope and HUTT positive 
response is looked into: 
Chronic obstructive 
airway disease 
Typical syncope Atypical syncope total 
present 2   (7.41%) 1   (5.88%) 3   (6.82%) 
absent 25 (92.59%) 16 (94.12%) 41 (93.18%) 
P= 0.845 
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Chronic obstructive 
airway disease 
HUTT negative HUTT positive total 
present 3   (10%) 0 3   (6.82) 
absent 27 (90%) 14 (100%) 41 (93.18%) 
P= 0.220 
In all, three out of 44 patients had COPD. Of these, two had a typical history of syncope, one 
had atypical syncope and all three were HUTT negative. No significant association could be 
found between COPD and typical syncope or HUTT positive response. 
CHARLSON COMORBIDITY SCORE 
 
The two tables below evaluate an association between Charlson comorbidity index, typical 
syncope and HUTT positive response: 
Charlson 
comorbidity index 
Typical syncope Atypical syncope total 
Low (0) 8   (29.63%) 6   (35.29%) 14 (31.82%) 
Medium (1-2) 13 (48.15%) 10 (58.82%) 23 (52.27%) 
High (3-4) 6   (22.22%) 1   (5.88%) 7   (15.91%) 
P= 0.353 
A typical history of syncope was not significantly associated with the Charlson 
comorbidity index. Majority (52.27%) of the patients had a medium score on the 
Charlson comorbidity index. 
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Charlson 
comorbidity index 
HUTT negative HUTT positive total 
Low (0) 11 (36.67%) 3   (21.43%) 14 (31.82%) 
Medium (1-2) 17 (56.67%) 6   (42.86%) 23 (52.27%) 
High (3-4) 2   (6.67%) 5   (35.71%) 7   (15.91%) 
P= 0.047 
Of the seven patients with a high Charlson comorbidity index, 5 had a positive HUTT 
response and the p value was significant. Thus, a statistically significant association was 
found between a high Charlson comorbidity index and HUTT positive response. 
 
 
 
 
MEDICATIONS: 
 
ACE INHIBITORS/ARBS 
 
The following two tables evaluate association between ACE inhibitor/ARB use, typical 
syncope and HUTT positive response: 
ACE inhibitor/ 
ARB intake 
Typical syncope Atypical syncope total 
yes 15 (55.56%) 9   (52.94%) 24 (54.55%) 
no 12 (44.44%) 8   (47.06%) 20 (45.45%) 
P= 0.865 
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ACE inhibitor/ 
ARB intake 
HUTT negative HUTT positive total 
yes 15 (50%) 9   (64.29%) 24 (54.55%) 
no 15 (50%) 5   (35.71%) 20 (45.45%) 
P= 0.375 
The p values were insignificant and so, no significant association could be found between 
ACE inhibitor/ARB intake and typical syncope or positive HUTT response. 
BETA BLOCKERS 
 
The two tables below evaluate association between the use of beta blockers, typical history of 
syncope and HUTT positive response: 
Beta blocker intake Typical syncope Atypical syncope Total  
yes 3   (11.11%) 3   (17.65%) 6   (13.64%) 
no 24 (88.89%) 14 (82.35%) 38 (86.36%) 
P= 0.538 
Beta blocker intake HUTT negative HUTT positive Total  
yes 4   (13.33%) 2   (14.29%) 6   (13.64%) 
no 26 (86.67%) 12 (85.71%) 38 (86.36%) 
P= 0.932 
The above two tables show that there is no statistically significant association between beta 
blocker intake, typical syncope and HUTT response. 
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CALCIUM CHANNEL BLOCKERS 
 
The following two tables evaluate association of calcium channel blockers use with typical 
syncope and positive response on HUTT: 
Calcium channel 
blockers use 
Typical syncope Atypical syncope total 
yes 4   (14.81%) 5   (29.41%) 9   (20.45%) 
no 23 (85.19%) 12 (70.59%) 35 (79.55%) 
P= 0.242 
 
 
Calcium channel 
blockers use 
HUTT negative HUTT positive total 
yes 4   (13.33%) 5   (35.71%) 9   (20.45%) 
no 26 (86.67%) 9   (64.29%) 35 (79.55%) 
P= 0.086 
The use of calcium channel blocker was not found to be significantly associated with typical 
syncope. Although a higher proportion of patients with positive response on HUTT test were 
taking CCBs as compared to patients with HUTT negative response, it was not found to be 
statistically significant. 
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DIURETICS: 
 
The association of diuretic use with Typical syncope and Positive response on HUTT test is 
evaluated in the following two tables: 
Diuretics use Typical syncope Atypical syncope total 
yes 8   (29.63%) 2   (11.76%) 10 (22.73%) 
no 19 (70.37%) 15 (88.24%) 34 (77.27%) 
P= 0.169 
Diuretics use HUTT negative HUTT positive total 
yes 5   (16.67%) 5   (35.71%) 10 (22.73%) 
no 25 (83.33%) 9   (64.29%) 34 (77.27%) 
P= 0.160 
Out of the 44 patients in the study, 10 (22.73%) of the patients were found to be on 
diuretics. Neither typical syncope nor a positive response on the HUTT test had a 
significant association with diuretic use. 
BENZODIAZEPINES 
 
The following two tables evaluate an association of benzodiazepine use with typical 
syncope and HUTT positive response: 
Benzodiazepine use Typical syncope Atypical syncope total 
yes 1   (3.7%) 2   (11.76%) 3   (6.82%) 
no 26 (96.3%) 15 (88.24%) 41 (93.18%) 
P= 0.302 
80 | P a g e  
 
 
Benzodiazepine use HUTT negative HUTT positive total 
yes 2   (6.67%) 1  (7.14%) 3   (6.82%) 
no 28 (93.33%) 13 (92.86%) 41 (93.18%) 
P= 0.953 
Of the 44 patients, only three were on benzodiazepines. There was no significant 
association of Typical syncope or HUTT positive response with benzodiazepine use in 
this study. 
 
ANTIDEPRESSANTS 
 
Of the 44 patients, only one patient was found to be on antidepressants. The patient 
had an atypical syncope and was HUTT negative. 
 
MINI COG TEST FOR COGNITIVE DECLINE  
 
The following two tables evaluate the association of cognitive decline with typical 
syncope and positive HUTT response: 
Mini cog test Typical syncope Atypical syncope total 
Negative for 
cognitive decline 
20 (74.07) 12 (70.59%) 32 (72.73%) 
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Positive for 
cognitive decline 
7   (25.93%) 5   (29.41%) 12 (27.27%) 
P= 0.800 
Mini cog test HUTT negative HUTT positive total 
Negative for 
cognitive decline 
20 (66.67%) 12 (85.71%) 32 (72.73%) 
Positive for 
cognitive decline 
10 (33.33%) 2   (14.29%) 12 (27.27%) 
P= 0.186 
12 (27.27%) of the 44 patients were found to be positive  for cognitive decline in mini 
cog test. But there was no statistically significant association of cognitive decline with 
typical syncope or HUTT positive response. 
HAND GRIP STRENGTH 
 
The following tables evaluate an association of hand grip strength with typical 
syncope and HUTT positive response 
 
 
Hand grip strength Typical syncope Atypical syncope total 
<20 2   (7.41%) 1   (5.88%) 3   (6.82%) 
20-30 11 (40.74%) 6   (35.29%) 17 (38.64%) 
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>30 14 (51.85%) 10 (58.82%) 24 (54.55%) 
P= 0.901 
 
Hand grip strength HUTT negative HUTT positive total 
<20 2   (6.67%) 1   (7.14%) 3   (6.82%) 
20-30 10 (33.33%) 7   (50%) 17 (38.64%) 
>30 18 (60%) 6   (42.86%) 24 (54.55%) 
P= 0.548 
No significant association was found between grip strength and typical syncope or 
HUTT positive response. 
HOLTER 
 
The following two tables evaluate the association of an abnormal response on Holter 
with typical syncope and HUTT positive response 
Holter  Typical syncope Atypical syncope total 
normal 17 (80.95%) 10 (71.43%) 27 (77.14%) 
abnormal 4   (19.05%) 4   (28.57%) 8   (22.86%) 
total 21 14 35 
P= 0.511 
Holter  HUTT negative HUTT positive total 
normal 19 (86.36%) 8   (61.54%) 27 (77.14%) 
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abnormal 3   (13.64%) 5   (38.46%) 8   (22.86%) 
total 22 13 35 
P= 0.091 
The association of an abnormal holter response with typical syncope is not significant. 
Although, a larger proportion of patients with holter positivity also had HUTT 
positivity, it was not found to be statistically significant. 
 
BASELINE ECG 
 
In the following two tables, we evaluate the association of typical response and HUTT 
positive result with a baseline ECG. The abnormalities looked for were a left bundle 
branch block and a bifascicular block and these were compared with a normal ECG: 
ECG Typical syncope Atypical syncope total 
normal 22 (81.48%) 13 (81.25%) 35 (81.4%) 
LBBB 2   (7.41%) 3   (18.75%) 5   (11.63%) 
Bifascicular block 3   (11.11%) 0 3   (6.98%) 
P= 0.236 
ECG HUTT negative HUTT positive total 
normal 24 (82.76%) 11 (78.57%) 35 (81.4%) 
LBBB 3   (10.34%) 2   (14.29%) 5   (11.63%) 
Bifascicular block 2   (6.9%) 1   (7.14%) 3   (6.98%) 
P= 0.929 
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43 of the 44 patients had an ECG at the baseline. Of these, majority (81.4%) of ECGs 
were normal. In this study, no association was found between the ECG changes and 
typical syncope or HUTT response. 
HUTT POSITIVITY AND VASOVAGAL SYNCOPE: 
 
HUTT 
history typical P-
Value yes no 
negative 
19 
(70.37) 
11 
(64.71) 
0.694 
  
positive  
8 
(29.63) 
6 
(35.29) 
 
TYPE OF HUTT RESPONSE: 
 
The following table evaluates the association of HUTT response with typical syncope: 
Type of HUTT 
response 
Typical syncope Atypical syncope Total  
Type 1 4   (50%) 2   (33.33%) 6   (42.86%) 
Type 2A 0 1   (16.67%) 1   (7.14%) 
Type 2B 2   (25%) 1   (16.67%) 3   (21.43%) 
Type 3 2   (25%) 2   (33.33%) 4   (28.57%) 
P= 0.626 
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Of the total of 14 patients who had HUTT positive response, 8 had presented with 
typical syncope and 6 with atypical syncope. The most common type of response with 
type 1 (42.86%) followed by type 3 (28.57), type 2B (21.43%) and type2A (7.14%). 
There was no association of typical syncope with any type of HUTT response. 
 
 
SAFETY OF HUTT TEST IN ELDERLY: 
 
None of the 14 patients who were positive for HUTT had any complication requiring 
hospitalization and all had spontaneous and complete recovery. Thus, in our study, it was 
found to be safe in the elderly. 
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UNIVARIATE ANALYSIS OF PATIENTS WITH HUTT POSITIVE RESPONSE: 
 
history of warmth history typical of vasovagal syncope P-value 
  YES  NO    
Yes 2 (25) 0 (0) 0.186 
No 6 (75) 6 (100) 
nausea       
Yes 1 (12.5) 0 (0) 0.369 
No 7 (87.5) 6 (100) 
history of sweating       
Yes 3 (37.5) 0 (0) 0.091 
No 5 (62.5) 6 (100) 
lightheadedness.       
Yes 2 (25) 0 (0) 0.186 
No 6 (75) 6 (100) 
blurred vision.       
Yes 5 (62.5) 0 (0) 0.016 
No 3 (37.5) 6 (100) 
history of dizziness       
Yes 6 (75) 0 (0) 0.005 
No 2 (25) 6 (100) 
epigastric discomfort       
No 8 (100) 6 (100)   
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hot flashes.       
No 8 (100) 6 (100)   
emotional distress       
Yes 1 (12.5) 0 (0) 0.369 
No 7 (87.5) 6 (100) 
orthostatic stress       
Yes 4 (50) 2 (33.33) 0.533 
No 4 (50) 4 (66.67) 
pain       
No 8 (100) 6 (100)   
situational       
Yes 1 (12.5) 0 (0) 0.369 
No 7 (87.5) 6 (100) 
situational       
No 1 (100)     
exertion       
Yes 1 (12.5) 0 (0) 0.369 
No 7 (87.5) 6 (100) 
position       
Yes 7 (87.5) 3 (50) 0.124 
No 1 (12.5) 3 (50) 
instrumentation       
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No 8 (100) 6 (100)   
 
  History typical of vasovagal 
syncope 
P-
Value 
hypertension YES (N= 8) NO (N = 6)   
present 7 (87.5) 5 (83.33) 0.825 
absent 1 (12.5) 1 (16.67) 
diabetes mellitus       
present 1 (12.5) 1 (16.67) 0.825 
absent 7 (87.5) 5 (83.33) 
ischemic heart disease       
present 1 (12.5) 2 (33.33) 0.347 
absent 7 (87.5) 4 (66.67) 
cerebrovascular accident       
present 0 (0) 1 (16.67) 0.231 
absent 8 (100) 5 (83.33) 
dyslipidemia       
present 7 (87.5) 3 (50) 0.124 
absent 1 (12.5) 3 (50) 
chronic obstructive pulmonary disease       
2 8 (100) 6 (100)   
type of hutt response       
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1 4 (50) 2 (33.33) 0.626 
2 0 (0) 1 (16.67) 
3 2 (25) 1 (16.67) 
4 2 (25) 2 (33.33) 
 
 
MULTIVARIATE ANALYSIS FOR HISTORY OF TYPICAL SYNCOPE: 
 
his Unadjusted  
OR (95% CI) 
p-value Adjusted  
OR (95% CI) 
p-value 
Blrd 38 (4.3, 337) 0.001 15.4 (1.4, 
173.5) 
0.027 
dizz 26.3 (4.6, 
148.4) 
<0.001 14.4 (2.0, 
104.6) 
0.008 
Orth  5.8 (1.4, 25.1) 0.018 2.92 (0.4, 
22.7) 
0.305 
 
A multivariate analysis of prodrome association with typical syncope was significant 
for the symptoms of blurred vision and dizziness but was insignificant for orthostatic 
stress. 
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MULTIVARIATE ANALYSIS FOR HUTT POSITIVITY: 
 
hutt Unadjusted  
OR (95% CI) 
p-value Adjusted  
OR (95% CI) 
p-value 
Blrd 0.6 (0.2, 2.1) 0.378 0.6 (0.1, 2.8) 0.495 
dizz 0.6 (0.2, 2.1) 0.395 0.7 (0.2, 3.0) 0.599 
Orth  1.1 (0.3, 4.1) 0.858 1.5 (0.4, 6.4) 0.560 
 
A multivariate analysis of the prodromal symptoms showed no significant association 
between HUTT positivity and symptoms. 
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DISCUSSION 
 
This study was an observational study among individuals aged more than 60 years 
visiting the outpatient departments of Geriatrics and Cardiology in a tertiary care 
hospital in South India. Since syncope is a common cause of falls and transient loss of 
consciousness, and in the lack of a gold standard for diagnosis of syncope, history and 
HUTT test form the cornerstones for the diagnosis. It is imperative to rule out 
abnormalities of cardiac structure, function and rhythm. Usually, evaluation of 
transient loss of consciousness is very expensive and in the absence of an adequate 
and good history and clinical examination, it may entail ordering expensive tests 
including MRI, EEG, loop recorders etc. So, if a diagnosis of neurocardiogenic 
syncope is made on the basis of history and inexpensive tests like HUTT, it saves the 
patient time and money. Also, in view of a good prognosis of neurocardiogenic 
syncope and effective strategies to prevent an episode, it also prevents undue distress 
to the patient. 
POPULATION PROFILE 
 
A total of 44 patients were recruited in our study from all over the country. 77.27% of 
the patients were in the age group 60-70 years and 22.73% were in the age group 70-
80 years. 
Males comprised 86.36% of the patients and the remaining 13.64% were females. 
In a study done by Bloomfield et al which looked at the effects of age on the outcome 
of head up tilt testing, a decline was found in the positivity of tilt table test with age. It 
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was fifty five per cent in the group of less than forty years age, fifty per cent in the age 
group forty to sixty four, thirty nine per cent in sixty five to seventy nine years and 
twenty three per cent in subjects more than eighty years of age. This age related 
decline was seen in both males and females.(42). In our study, this age related decline 
in HUTT positivity was not seen as 26.48% of patients in the age group 60-70 were 
HUTT positive and 50% patients in the age group 70-80 were HUTT positive. This 
difference could be due to a small sample size of our study. 
PRODROMAL SYMPTOMS: 
 
Typical syncope is characterized by the presence of antecedent premonitory 
symptoms, most important of which were evaluated in this study. 
In a study by Sheldon et al, it was found that the features of history that were 
contributory to tilt positive primary syncope diagnosis were exposure to pain or a 
medical procedure, warmth or diaphoresis and association with prolonged standing or 
sitting. (27) In another study, the most commonly reported prodromal signs and 
symptoms were pallor, dizziness and diaphoresis. Also, typical features of syncope 
were less common in males and the elderly.(18) However, in our study no significant 
association between any of these prodromes was found with positive response to 
HUTT test. This was probably due to a small sample size. Like this study, our study 
also had atypical presentation in males and all the females had typical syncope. 
In our study, of the prodromal symptoms evaluated, the symptoms of sweating, light 
headedness, blurred vision and orthostatic stress had statistically significant 
associations with typical syncope in the univariate analysis and the prodrome of 
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warmth approached statistical significance. In a multivariate analysis, the prodromes 
of blurred vision and dizziness had statistically significant association with typical 
syncope 
TRIGGERING FACTORS: 
 
Among the triggering factors, orthostatic stress and a standing position were found to 
have a significant association with typical syncope. 68.18% of the patients had 
syncope in the standing position. A history of exertion as a trigger approached 
statistical significance. 
COMORBIDITIES: 
 
We studies various common comorbidities in the elderly including hypertension, 
diabetes mellitus, ischemic heart disease, cerebrovascular accident, dyslipidemia and 
COPD. The most common comorbidity in our study was found to be hypertension 
with 65.91% of the patients being hypertensives. The next most common comorbidity 
was dyslipidemia being present in 50% of the patients followed by diabetes mellitus 
(31.82%), ischemic heart disease (15.91%), COPD (6.82%) and Cerebrovascular 
accident (4.55%). 
Among these, the comorbidities of hypertension and dyslipidemia approached 
significance for association with a positive HUTT response with p values of 0.058 and 
0.052 respectively.  
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None of these comorbidities were found to have a statistically significant association 
with a history of typical syncope. 
A study was done in 164 elderly subjects by Paul B et al to assess the influence of 
medication use and comorbidities on the outcome of the tilt table test in patients in the 
geriatric age group and  the variables assessed were age, gender, comorbid conditions 
of diabetes mellitus, hypertension, cerebrovascular disease and chronic heart failure. 
Medications included were angiotensin converting enzyme inhibitors, beta blockers, 
calcium channel blockers, diuretics, digoxin, opioids, benzodiazepines, 
antidepressants, digoxin and non steroidal anti-inflammatory drugs. In this study, the 
tilt table test outcome was uninfluenced by comorbidities(43). With regard to the 
comorbidities, our study too had no association with HUTT response. 
CHARLSON COMORBIDITY INDEX: 
 
There was no significant association of a high Charlson comorbidity index with 
history of typical syncope. But of the 7 patients with a high Charlson comorbidity 
index, 5 had positive HUTT response and this was statistically significant with a p 
value of 0.047. no data in literature was found in this regard. 
MEDICATIONS: 
 
Polypharmacy is commonplace in the elderly, especially due to multiple comorbidities 
and many of the medications predispose them to recurrent falls. Our study looked at 
several groups of medications viz. ACE inhibitors/ARBs, beta blockers, CCBs, 
diuretics, BZDs and antidepressants. The most commonly used group of medications 
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was found to be ACE inhibitors/ARBs as 54.55% of the patients were on the same. 
This was followed by diuretics (22.73%), CCBs (20.45%), beta blockers (13.64%), 
BZDs and antidepressants. 
None of these medications were found to have a statistically significant association 
with typical syncope or a positive HUTT response.  
A study done by Paul B et al done in one hundred and sixty four elderly subjects to 
assess the influence of medication use on the outcome of the tilt table test in patients 
in the geriatric age group. In this study, the medications included were angiotensin 
converting enzyme inhibitors, beta blockers, calcium channel blockers, diuretics, 
digoxin, opioids, benzodiazepines, antidepressants, digoxin and non steroidal anti-
inflammatory drugs. It showed that the tilt table test outcome was uninfluenced by 
long term medications. Although a long term calcium channel blocker intake was 
associated with transient orthostasis and drop in blood pressure but it did not influence 
the heart rate or the outcome of tilt table test.(43). Similar to this study, our study too 
did not find a statistically significant association between long term medications and 
HUTT positivity. 
MINI COG TEST FOR COGNITIVE DECLINE: 
 
The risk of cognitive decline increases with advancing age. So does the risk of falls. 
So, this study also looked at the association between syncope, HUTT positivity and 
cognitive decline. The test used was a mini cog test which is a short screening test of 
cognition. In our study, according to this screening tool, 27.27% of the patients were 
found to be positive for cognitive decline. However, there was no statistically 
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significant association of cognitive decline with typical syncope or a HUTT positive 
response. A thorough literature search was done but we did not come across a study 
showing association of cognition with syncope. 
HAND GRIP STRENGTH 
 
A low hand grip strength is a marker of frailty which is another risk factor for falls. In 
this study, using a Jamar hand dynamometer, we found that 6.82% of the patients had 
a grip strength less than 20kg, 38.64% of the patients had a grip strength of 20-30kg 
and 54.55% had grip strength more than 30kg. Our study also found that the grip 
strength was not associated with a history of typical syncope or a positive HUTT 
response. Literature search did not reveal any study done on hand grip in relation with 
syncope. 
 
 
HUTT RESPONSE 
 
A study done by Ravieli et al which was a comparative study of diagnostic accuracy 
of sublingual nitroglycerin and low dose isoproterenol in seventy one patients with 
unexplained syncope without organic heart disease and thirty control subjects who 
were asymptomatic it was found that with sublingual nitroglycerin, the positivity rate 
was 49% .(36).  
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In our study, of the 44 patients in the study presenting with a history of syncope, 14 
were positive for HUTT which was 31.81% positivity rate. This difference could be 
due to a smaller sample size and a different patient profile. 
Of the 14 patients who had HUTT positive response in this study, 8 had a history of 
typical syncope and 6 had atypical syncope. The most common response was type 1 
(42.86%) followed by type 3 (28.57%), type 2B (21.43%) and type 2A (7.14%). There 
was no association of typical syncope with any type of HUTT response. 
.The findings of our study were different from a study done to assess the efficacy of 
tilt training in patients with vasovagal syncope in which, forty patients with recurrent 
vasovagal syncope received tilt training using the tilt table. In this study, a type 1 or 
mixed response was found in seventeen patients (42.5%), type 2 or cardioinhibitory 
response was found in twenty two patients (55%) and a type 3 or vasodepressive 
response was found in one patient (2.5%). (57) 
This difference could be due to different patient profiles in the two studies. 
 
ECG AND HOLTER 
 
A majority of the patients had a normal ECG (81.4%) and no association was found 
between ECG changes and typical syncope or HUTT response.  
In all, 35 of the 44 patients in the study had undergone a holter test. 22.86% of these 
patients had abnormal response on holter. No significant association was found 
between abnormal Holter and typical syncope. Although a larger proportion of 
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patients with holter positivity also had a positive response on HUTT, this association 
was not found to be statistically significant. 
Thus, our study highlights the need for a good history and targeted tests to diagnose 
neurocardiogenic syncope in elderly. 
CONCLUSIONS 
 
1. The HUTT positivity for patients with a history of syncope was 31.8%.  
2. Among the HUTT responses, type 1 response was the most common in our 
study. 
3. There was no significant difference between typical and atypical syncope for 
HUTT positivity. 
4. Among the prodromal symptoms, dizziness, light headedness, blurred vision 
and sweating had a significant association with typical syncope but not with 
HUTT positivity. 
5. Among the triggering factors prolonged orthostatic stress and standing position 
had a significant association with typical syncope. 
6. Although none of the comorbidities had statistically significant association 
with either typical syncope or HUTT positivity, the comorbid burden as 
measured by Charlson comorbidity index had a statistically significant 
association with positive response to HUTT test. 
7. A good history is of paramount importance in the diagnosis of syncope. 
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Appendix-2:  Patient information sheet: 
 
STUDY OF ELDERLY PATIENT UNDERGOING HUTT 
 
Head Up Tilt Table Test (HUTT) is a diagnostic test usually done for patients who suffer 
from black outs. There can be several causes for this problem. HUTT helps in diagnosing 
one of them known as vasovagal syncope. This study aims at improving our understanding 
and usefulness of HUTT test.  
Participating in the study is entirely voluntary and you can decide to withdraw from the 
study at any point in time. This will not affect the treatment you will be undergoing in this 
hospital.  
 
What is HUTT?  
 
For a tilt table test, you begin by lying flat on a table. Straps are put around your body to 
hold you in place. Before the test begins, a nurse will help you get ready. The nurse will start 
an IV (intravenous) line and monitors are connected for measuring blood pressure, heart 
rate. This is so the doctors and nurses may give you medications and fluids during the 
procedure if necessary. After about 5 minutes of lying flat, the table is quickly tilted to raise 
your body to a head-up position — simulating a change in position from lying down to 
standing up.  
The table will then remain upright for up to 15 minutes, while your heart rate and blood 
pressure are monitored. After 15 minutes, Sorbitrate 5mg will be given and asked to keep 
under the tongue. The table will continue to remain upright for another 15minutes.You may 
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feel nothing at all during the head-up tilt table test, or you may feel giddy. Some people lose 
consciousness for a short time during the test. If you feel giddy or lose consciousness, the 
table will immediately be made flat.  
 
What will I have to do to take part in the part?  
i. Sign the consent form  
ii. Give personal details  
iii. Give a detailed history  
iv. Give consent for examination including pulse, Blood pressure and examination of the 
chest  
v. Undergo HUTT test  
 
 
Is there any risk?  
 
The patient will not have any risk in participating in the study. Rarely, the patient may 
experience a black out while the test is being performed.  
 
 
Will I have to pay for investigations?  
 
Patients will not be charged for this study.  
 
 
What advantage will I get from this study?  
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a) By participating in this study, the patient is taught about vasovagal syncope and 
interventions to avoid that.  
b) The patients will be taught about different measures used and specific exercises to avoid 
a black out, if the test is positive.  
 
 
Will my personal details be kept confidential?  
 
We aim to publish the results of this study in a medical journal, but you will not be 
identified by name in any publication or presentation of results. However, your medical 
notes may be reviewed by people associated with the study, without your additional 
permission.  
 
 
Can I withdraw from this study after it starts?  
 
Participation in this study is entirely voluntary; you can withdraw from the study at any 
time. Refusal to participate will not involve any loss of benefits to which you are otherwise 
entitled.  
 
 
If you have any further questions, please ask Dr. Rakesh Mishra  
You can contact me on  
Phone 04162282943 / 80151806589  
Email: mishrarakesh.dr@gmail.com 
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Appendix-3 PROFORMA 
                                      
1) HOSPITAL NO.         
2) AGE  
3) SEX     1] MALE 
        2] FEMALE 
4) SOCIOECONOMIC STATUS( Kuppuswamy scale)  
1) UPPER 
2) UPPER MIDDLE 
3) UPPER LOWER 
4) LOWER 
 
HISTORY 
------------ 
5) HISTORY 
1] TYPICAL   OF VASOVAGAL SYNCOPE Y(1)  N(2) 
2] DURATION OF SYMPTOMS  
        1) Days  
        2) Months 
        3) Years 
    
3] FREQUENCY OF SYMPTOMS 
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    No of episodes   
               
4 ] PRODROME  
    Warmth – Y (1) N (2) 
    Nausea – Y (1) N (2) 
    Sweating Y (1) N (2) 
    Light headedness Y(1) N(2) 
    Blurred vision  Y(1) N(2) 
    Dizziness  Y(1) N(2) 
   Epigastric discomfort  Y(1) N(2) 
     Hot ﬂashes Y(1) N(2) 
5] TRIGGERS  
    1) EMOTIONAL DISTRESS 
    2) ORTHOSTATIC STRESS 
     3) PAIN 
    4) SITUATIONAL 
                                      1) COUGH 
                                      2) MICTURITION 
                                      3) DEFECATION 
                                      4) SWALLOW 
                                        
         5) EXERTION 
                          Y(1) N(2) 
         6) POSITION 1) STANDING 
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                               2) SITTING 
                               3) SUPINE 
                               4) WALKING 
7) INSTRUMENTATION 
6) COMORBIDITIES 
 1) HYPERTENSION  Y (1) N(2)    YEARS 
 2) DIABETES MELITUS Y (1) N(2)    YEARS 
             3) ISCHEMIC HEART DISEASE Y (1) N(2)    YEARS 
             4) CEREBROVASCULAR ACCIDENT Y (1) N(2)    YEARS 
             5) DYSLIPIDEMIA Y (1) N(2)    YEARS 
             6) COPD Y (1) N(2)    YEARS 
7] CHARLSON COMORBIDITY SCORE 
       1) LOW - 0 
       2) MEDIUM – 1-2 
       3) HIGH – 3-4 
      4) VERY HIGH >5 
8] MEDICATIONS 
          ACE INHIBITORS  Y(1) N(2) 
           BETABLOCKERS Y(1) N(2) 
           CALCIUM CHANNEL BLOCKERS Y(1) N(2) 
           DIURETICS Y(1) N(2) 
           BENZODIAZEPINES Y(1) N(2) 
119 | P a g e  
 
           ANTIDEPRESSANTS Y(1) N(2) 
GERIATRIC ASSESSMENT 
-------------------------------- 
9] MINI COG 
1) Negative for cognitive impairment 
  3 recalled words  OR 1-2 recalled words + normal CDT  
2) Positive for cognitive impairment  
1-2 recalled words + abnormal CDT OR  0 recalled words  
10] ADL score 
  Barthel Index - 
11] HAND GRIP  
       Score -  
12] TIMED GET UP AND GO -      
13] GAIT SPEED - 
14] PULSE  
 1) RATE 
              2) RHYTHM (1) Regular  
                                  (2) Irregular 
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15] BLOOD PRESSURE 
             1) BASELINE 
2) ORTHOSTATIC FALL in Blood pressure 
                    Y(1) N(2) 
 
16] CVS EXAMINATION 
    1) NORMAL 
    2) LEFT HEART FAILURE  Y(1) N(2) 
     
   
17] HUTT 
1) NEGATIVE 
2) POSTITIVE 
    1] TYPE 1 
    2] TYPE 2A 
    3] TYPE 2B 
    4] TYPE 3 
3) TIME TO SYNCOPE – 
4) Complications Y(1) N(2) 
OTHER INVESTIGATIONS 
18] ECG  
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        1) NORMAL 
        2) LBBB 
        3) BIFASCICULAR BLOCK    
19] ECHO diagnosis 
20) HOLTER  
    1) Normal 
    2) Abnormal 
21] HAEMOGLOBIN  
22] MANAGEMENT 
1) CONSERVATIVE 
2) MEDICATIONS 
23] FOLLOW UP 
           Improvement in symptoms as said by the patient 
                   1) <25% 
                   2) 25-50% 
                   3) 50- 75% 
                  4) >75% 
24) ELECTROPHYSIOLOGICAL STUDIES 
25) MRI BRAIN 
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APPENDIX 4 Kuppusamy socioeconomic scale 
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APPENDIX 5- Timed Get Up and Go Test 
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APPENDIX-6 BARTHEL INDEX 
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APPENDIX 7 HAND GRIP 
 
Grip strength: JAMAR Hand Dynamometer 
 The JAMAR Adjustable Hand Dynamometer offers many features for both routine 
screening work and for evaluating hand trauma and disease. 
 To assess the grip strength of the dominant hand. 
Description: 
 The JAMAR displays grip force in pounds and kilograms—200 pounds or 90 kilograms 
maximum reading. 
Proceedure: 
 Position: Seated, shoulder adducted and neutrally rotated, elbow 
flexed at 90º, forearm in neutral position, and wrist between 0º and 
30º dorsiflexion and between 0º and 15º ulnar deviation. 
 3 trials provided with 2-minute break. 
 The final score will be taken the average of 3 trials 
Benefits: 
Accurate and Reproducible. 
The JAMAR is isometric in use, regardless of grip strength. The hand grasp is both 
comfortable and effective. These features combine to ensure accurate, and reproducible 
results. 
Gender 
60 – 64Yrs 
(Pounds/Kgs) 
65 – 69Yrs 
(Pounds/Kgs) 
70 – 75Yrs 
(Pounds/Kgs) 
75+Yrs 
(Pounds/Kgs) 
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Right 
Hand 
Male  - 89.7/40.7 
Female - 55.1/25 
Male - 91.9/41.7 
Female - 45.6/20.7 
Male - 79.3/36 
Female - 49.6/22.5 
Male - 65.7/29.8 
Female - 42.6/19.3 
Left 
Hand 
Male – 76.8/34.9 
Female - 45.7/20.72 
Male - 76.8/34.8 
Female - 41.0/18.6 
Male – 64.8/29.3 
Female - 41.1/18.6 
Male - 55.0/25 
Female - 37.6/17 
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APPENDIX 8 CHARLSON COMORBIDITY INDEX SCORE 
                         
 
 
 
 
 
 
129 | P a g e  
 
 
APPENDIX 9 MINI-COG 
Instructions 
ADMINISTRATION SPECIAL INSTRUCTIONS 
1.  Get patient’s attention and ask him or her 
to remember three unrelated words. Ask 
patient to repeat the words to ensure the 
learning was correct 
 Allow patient three tries, then go to 
next item. 
 The following word lists have been 
validated in a clinical stud 
Version 1 •  Banana • Sunrise • Chair 
Version 2 • Daughter • Heaven • 
Mountain 
Version 3 •  Village • Kitchen • Baby 
Version 4 • River • Nation • Finger 
Version 5 •  Captain • Garden • 
Picture 
Version 6 • Leader • Season • Table 
2.  Ask patient to draw the face of a clock. 
After numbers are on the face, ask patient to 
draw hands to read 10 minutes after 11:00 
(or 20 minutes after 8:00). 
  Either a blank piece of paper or a 
preprinted circle (other side) may be used. •  
A correct response is all numbers placed in 
approximately the correct positions AND the 
hands pointing to the 11 and 2 (or the 4 and 
8). •  These two specific times are more 
sensitive than others. •  A clock should not 
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be visible to the patient during this task. •  
Refusal to draw a clock is scored abnormal. •  
Move to next step if clock not complete 
within three minutes 
  
3.  Ask the patient to recall the three words 
from Step 1. 
Ask the patient to recall the three words you 
stated in Step 1. 
Scoring 
3 recalled words     Negative for cognitive impairment 
1-2 recalled words + normal CDT   Negative for cognitive impairment 
1-2 recalled words + abnormal CDT   Positive for cognitive impairment 
0 recalled words    Positive for cognitive impairment 
 
References 
1.  Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive “vital 
signs” measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 
2000;15(11):1021-1027.  
2. Borson S, Scanlan JM, Chen P, Ganguli M. The Mini-Cog as a screen for dementia: 
validation in a population-based sample. J Am Geriatr Soc. 2003;51(10):1451-1454.  
3. McCarten JR, Anderson P Kuskowski MA et al. Finding dementia in primary care: the 
results of a clinical demonstration project. J Am Geritr Soc. 2012;60(2):210-217. 
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APPENDIX 10 CLOCK DRAWING TEST 
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APPENDIX- 11 ABSTRACT 
 
THE OUTCOME OF HEAD UP TILT TEST IN ELDERLY 
PATIENTS WITH TYPICAL VERSUS ATYPICAL FEATURES 
OF SYNCOPE 
 
BACKGROUND 
Syncope is a common cause of recurrent falls and transient loss of consciousness in 
the elderly. In the absence of a gold standard test for diagnosing syncope, a clinical 
history and HUTT test form the cornerstone of diagnosis of syncope. But in many 
instances, the evaluation of a fall and transient loss of consciousness entails 
unnecessary expensive investigations including brain imaging, loop recorders, EEG 
and undue distress to the patient. Since neurocardiogenic syncope is a benign 
condition which can be prevented by simple measures, its diagnosis by history and 
inexpensive tests like HUTT save the patient unnecessary expenditure and stress. 
 
AIM 
To determine the outcome of head up tilt test in elderly patients with typical versus 
atypical features of syncope. 
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OBJECTIVES 
1) To determine the outcome of head up tilt test in elderly patients aged sixty 
years and more who present with typical versus atypical history of syncope. 
2) To study the occurrence of various prodromal symptoms in syncope and their 
association with HUTT positivity. 
3) To study the association of HUTT response and comorbidities and comorbid 
burden. 
4) To study the association of syncope, type and HUTT response with 
medications taken by the subject. 
5) To study the association of syncope and  HUTT response with hand grip 
strength and mini cog test. 
6) To study the association of syncope and HUTT response with result of Holter 
test. 
 
METHODS 
We conducted an observational study of the patients aged 60 and above 
presenting to the departments of Geriatrics and Cardiology with a history of 
neurocardiogenic syncope from May 2017 to October 2017. The participants 
who were ordered HUTT tests from the OPD were recruited. We looked at the 
association of the type of syncope whether typical or atypical based on the 
history and outcome of their HUTT test. We also evaluated them for 
association of type of syncope and HUTT response with prodromal symptoms, 
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individual comorbidities, cumulative comorbid burden based on their Charlson 
comorbidity index, medications, triggering factors, ECG and Holter. 
FINDINGS 
Between May 2017 and October 2017, we recruited 44 patients for the study. 
77.27% were in the age group 60-70 years and the rest in 70-80 years. 27 of the 
44 patients had typical syncope and 17 had atypical syncope. Of these 44 
patients, 30 had a negative response to the HUTT test and 14 had positive 
response. There was no association between the type of syncope (whether 
typical or atypical) and HUTT response. The prodromal symptoms of sweating, 
light headedness and blurred vision were significantly associated with typical 
syncope but not with a positive HUTT response. Among the triggering factors, 
orthostatic stress and a standing position had a significant association with 
typical syncope but not with HUTT positivity. None of the comorbidities 
studied (Diabetes, Hypertension, Dyslipidemia, Ischemic heart disease, 
Cerebrovascular accident or COPD) had any association with either Typical 
syncope or HUTT positivity. Also, none of the  medications studied (ACE 
inhibitors/ARBs, Beta blockers, CCBs, Diuretics, Benzodiazepines or 
Antidepressants had any association with HUTT response or typical syncope. 
Cognition and grip strength were also not found to have any association with 
either of these. The most common type of HUTT response was mixed (type1) 
which was seen in 42.86% of the patients followed by type 3 (28.51%), type 
2B (21.43%) and type 2A (7.14%). No association was found between typical 
syncope or HUTT response and ECG or Holter. 
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CONCLUSION 
As per this study, the positivity rate of HUTT for patients with a history of 
syncope is 31.8%. Also, there is no association between typical or atypical 
syncope and HUTT positivity. Dizziness, light headedness, blurred vision and 
sweating are significantly associated with typical syncope. None of the 
comorbidities or medications have an association with syncope or HUTT 
response but the comorbid burden has a significant and positive association 
with positive HUTT response. So, history is of paramount importance in 
diagnosing patients with syncope and can be aided by a HUTT test. 
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APPENDIX 12- RAW DATA FROM THE STUDY: 
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